<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sci-Illustrate on Medium]]></title>
        <description><![CDATA[Stories by Sci-Illustrate on Medium]]></description>
        <link>https://medium.com/@sci-illustratestories?source=rss-1c47669525b4------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/2*zbdo1_n9mBrIU-kvxSu6LA.png</url>
            <title>Stories by Sci-Illustrate on Medium</title>
            <link>https://medium.com/@sci-illustratestories?source=rss-1c47669525b4------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 16:40:40 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@sci-illustratestories/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Osteoclasts]]></title>
            <link>https://sci-illustratestories.medium.com/osteoclasts-3f8a74bd8611?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/3f8a74bd8611</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Wed, 22 Jul 2026 20:10:43 GMT</pubDate>
            <atom:updated>2026-07-22T20:10:43.974Z</atom:updated>
            <content:encoded><![CDATA[<p>Breaking Down and Balancing Bone</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*1AF9lG9z9FbL_CY3wwkA0w.gif" /></figure><p><em>Credit: Art by Alexandra Banbanaste. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Osteoclasts are the specialized sculptors of the skeletal system, uniquely tasked with bone resorption. Derived from the hematopoietic lineage, these multinucleated cells form through the fusion of monocyte precursors under the direction of macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-kappa B ligand (RANKL) [1–2]. As osteoclast precursors fuse into their mature form, they activate tightly regulated machinery, acidifying the bone surface and degrading the matrix precisely. This finely tuned process doesn’t just shape the skeleton; it safeguards mineral balance across the entire body. Pioneering studies have revealed their tightly regulated machinery as essential for bone turnover and skeletal renewal [3].</p><p><strong>Resorption at Ruffled Border</strong></p><p>The hallmark of an active osteoclast is the ruffled border, a dynamic proton-secreting membrane that establishes the acidic microenvironment needed to dissolve bone. Formed through precise vesicle trafficking and cytoskeletal remodeling, this polarized domain targets areas of bone for controlled resorption [4]. Within this sealed-off zone, osteoclasts secrete proteolytic enzymes like cathepsin K and matrix metalloproteinases (MMPs) to break down the organic matrix [5]. Recent studies have uncovered how integrin signaling, cellular polarity, and actin ring formation converge to localize this machinery with precision [4]. Far from chaotic destruction, osteoclastic resorption is a spatially restricted, mechanosensitive process, fine-tuned to remodel the skeleton without compromising its strength.</p><p><strong>Signaling and Skeletal Consequences</strong></p><p>Osteoclast differentiation occurs through a complex interaction of signaling pathways, with RANK-RANKL interactions setting the stage. This binding event activates NF-κB, JNK, and MAPK pathways, ultimately triggering the expression of NFATc1, the master transcription factor that drives osteoclastogenesis [6]. Foundational research highlighted NFATc1’s central role, forging a critical link between immune signaling and skeletal remodeling, and helping to establish the field of osteoimmunology [7]. Building on this, recent studies have mapped the epigenetic landscape of osteoclasts, revealing how chromatin accessibility and coregulatory networks tailor gene expression in response to developmental cues and inflammatory stimuli [8]. Osteoclastogenesis is not just a product of bone biology, but a finely tuned intersection of immunology, cytokine signaling, and epigenetic control that defines when, where, and how bone resorption occurs.</p><p><strong>Breaking Down to Build Up</strong></p><p>Bone remodeling is a precisely coordinated process that starts with the resorption by osteoclasts and ends with the formation by osteoblasts. However, osteoclasts do more than just decompose bone; they also play a role in directing subsequent actions. As they degrade the matrix, they release coupling factors like transforming growth factor-beta (TGF-β) and insulin-like growth factors (IGF-1), which serve as biochemical signals to recruit and activate osteoprogenitors at the resorption site [9]. This elegant handoff ensures that resorption and formation remain in sync. Recent studies have shed light on this temporal and spatial feedback loop, showing how osteoclasts and osteoblasts communicate to maintain skeletal integrity [10]. When these coupling signals are disrupted, the balance can be upset, resulting in disorders such as osteoporosis and Paget’s disease, where bone remodeling becomes unregulated and harmfu [11–12].</p><p><strong>Hormones and Homeostasis</strong></p><p>Osteoclasts respond dynamically to hormonal and mechanical cues that govern skeletal health. Parathyroid hormone (PTH) promotes bone resorption by boosting RANKL expression in osteoblast-lineage cells, while calcitonin acts as a direct brake on osteoclast activity. Estrogen adds another layer of regulation, suppressing osteoclast formation and promoting their apoptosis. Its absence, particularly after menopause, is a major stimulus for enhanced bone turnover [13]. Recent research reveals that estrogen deficiency heightens oxidative stress in osteoclast precursors, amplifying bone degradation with age [14]. Mechanical signals also play a role; studies show that mechanical unloading alters cytoskeletal tension and integrin pathways, priming osteoclasts for recruitment and activation [15]. These together position osteoclasts as highly sensitive effectors, targeted by hormonal signal and biomechanical input to reshape the skeleton in real time.</p><p><strong>Build Failure</strong></p><p>Whether overactive or underpowered, dysfunctional osteoclasts disrupt the delicate balance of bone remodeling. In inflammatory diseases like rheumatoid arthritis and periodontitis, cytokines such as TNF-α, IL-1β, and IL-6 amplify osteoclastogenesis, overwhelming regulatory feedback and driving excessive bone loss [16–17]. On the other end of the spectrum, inherited disorders like osteopetrosis reveal the consequences of failed resorption. Mutations in genes such as <em>CLCN7</em>, <em>PLEKHM1</em>, and <em>TCIRG1, </em>key players in acidification and cytoskeletal dynamics, halt osteoclast function, resulting in overly dense but brittle bones [18]. Whether through hyperactivity or deficiency, these pathologies underscore the osteoclast’s essential role in maintaining skeletal integrity.</p><p>Once dismissed as mere degraders, osteoclasts are now recognized as precision sculptors of the skeleton, carefully dismantling bone to make way for renewal. Guided by immune cues, hormonal signals, mechanical forces, and genetic blueprints, these cells do more than resorb, they reshape, regulate, and release. When osteoclasts fall out of sync, whether through aging, inflammation, or inherited mutation, the ripple effects compromise skeletal integrity. To restore balance in bone and beyond, we must understand osteoclasts not as destroyers, but as guardians of skeletal equilibrium.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Hiroshi Takayanagi Lab: University of Tokyo, Tokyo, Japan <a href="http://www.osteoimmunology.com/en/en_profile_takayanagi.html">http://www.osteoimmunology.com/en/en_profile_takayanagi.html</a></li><li>Teitelbaum Lab: WashU Medicine, St Louis, MO, USA <a href="https://pathology.wustl.edu/people/steven-teitelbaum-md/">https://pathology.wustl.edu/people/steven-teitelbaum-md/</a> LinkedIn: <a href="https://www.linkedin.com/showcase/washu-pathology-immunology/">https://www.linkedin.com/showcase/washu-pathology-immunology/</a> X: @washu_pathology</li><li>Baron-Gori Lab: Harvard School of Dental Medicine, Boston, MA, USA <a href="https://www.hsdm.harvard.edu/baron-gori-laboratory">https://www.hsdm.harvard.edu/baron-gori-laboratory</a></li><li>Odgren Lab: UMass Chan Medical School, North Worchester, MA, USA <a href="https://www.umassmed.edu/odgren-lab/">https://www.umassmed.edu/odgren-lab/</a></li><li>Alliston Lab: University of California San Francisco, CA, USA <a href="https://allistonlab.ucsf.edu/research">https://allistonlab.ucsf.edu/research</a></li><li>Lane Lab: UC Davis, Sacramento, CA, USA <a href="https://health.ucdavis.edu/musculoskeletalhealth/bios/lane.html">https://health.ucdavis.edu/musculoskeletalhealth/bios/lane.html</a></li><li>Choi Lab: Perelman School of Medicine UPenn, Philadelphia, PA, USA <a href="https://www.med.upenn.edu/apps/faculty/index.php/g20001900/p14632">https://www.med.upenn.edu/apps/faculty/index.php/g20001900/p14632</a></li><li>Almeida Lab: University of Arkansas for Medical Science, Little Rock, AR, USA <a href="https://ortho.uams.edu/maria-schuller-almeida-ph-d/">https://ortho.uams.edu/maria-schuller-almeida-ph-d/</a></li><li>Xu Feng Lab: UAB School of Medicine, Birmingham, AL, USA <a href="https://apps.medicine.uab.edu/facultydirectory/FacultyData.asp?FacultyTypeID=IM&amp;FID=27473">https://apps.medicine.uab.edu/facultydirectory/FacultyData.asp?FacultyTypeID=IM&amp;FID=27473</a></li><li>Masaru Ishii Lab: The University of Osaka, Osaka, Japan <a href="https://www.ifrec.osaka-u.ac.jp/en/laboratory/masaru_ishii/index.htm">https://www.ifrec.osaka-u.ac.jp/en/laboratory/masaru_ishii/index.htm</a></li></ol><h4><strong>References</strong></h4><ol><li>Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. <em>Nature</em>. 2003;423(6937):337–342.</li><li>Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. <em>Nature</em>. 1999;397(6717):315–323.</li><li>Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. <em>J Clin Invest</em>. 2000;106(12):1481–1488.</li><li>Feng X, Teitelbaum SL. Osteoclasts: New Insights. <em>Bone Res</em>. 2013;1(1):11–26.</li><li>Zou W, Teitelbaum SL. Integrins, growth factors, and the osteoclast cytoskeleton. <em>Ann N Y Acad Sci</em>. 2010;1192:27–31.</li><li>Jiang T, Xia T, Qiao F, Wang N, Jiang Y, Xin H. <em>Role and regulation of transcription factors in osteoclastogenesis.</em> Int J Mol Sci. 2023;24(22):16175.</li><li>Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. <em>J Bone Metab</em>. 2014;21(4):233–241.</li><li>Deb M, Laha D, Maity J, Das H. SETD2-mediated epigenetic regulation of noncanonical Wnt5A during osteoclastogenesis. <em>Clin Epigenetics</em>. 2021;13(1):192.</li><li>Shiwaku Y, Neff L, Nagano K, et al. The Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium Phosphates. <em>PLoS One</em>. 2015;10(7):e0132903</li><li>Greenblatt MB, Park KH, Oh H, et al. CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts. <em>J Exp Med</em>. 2015;212(8):1283–1301.</li><li>Seitz S, Priemel M, Zustin J, et al. Paget’s disease of bone: histologic analysis of 754 patients. <em>J Bone Miner Res</em>. 2009;24(1):62–69. doi:10.1359/jbmr.080907</li><li>Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. <em>Endocr Rev</em>. 2008;29(2):155–192. doi:10.1210/er.2007–0014</li><li>Ben-awadh AN, Delgado-Calle J, Tu X, et al. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. <em>Endocrinology</em>. 2014;155(8):2797–2809.</li><li>Iantomasi T, Romagnoli C, Palmini G, et al. Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs. <em>Int J Mol Sci</em>. 2023;24(4):3772.</li><li>Wang L, You X, Zhang L, Zhang C, Zou W. Mechanical regulation of bone remodeling. <em>Bone Res</em>. 2022;10(1):16. Published 2022 Feb 18.</li><li>Wang W, Zheng X, Wang H, Zuo B, Chen S, Li J. Mechanical Unloading Promotes Osteoclastic Differentiation and Bone Resorption by Modulating the MSC Secretome to Favor Inflammation. <em>Cell Transplant</em>. 2024;33:9636897241236584.</li><li>Barvencik F, Kurth I, Koehne T, et al. CLCN7 and TCIRG1 mutations differentially affect bone matrix mineralization in osteopetrotic individuals. <em>J Bone Miner Res</em>. 2014;29(4):982–991.</li><li>Pangrazio A, Poliani PL, Megarbane A, et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. <em>J Bone Miner Res</em>. 2006;21(7):1098–1105.</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/1*9qNUMr_WMIRCjrp3L7Q1WQ.jpeg" /></figure><p><strong>DR. CHRISTY KESTNER<br>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*kM_1eYzYIOYmk2wMkiaFLA.jpeg" /></figure><p><strong>ALEXANDRA BANBANASTE</strong></p><p><strong>Contributing Artist</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Alexandra Banbanaste is completing her Master’s in Chemical Engineering at Ecole Polytechnique Fédérale de Lausanne, where she studied neuroscience, chemistry, and biology.</p><p>Apart from being a passionate scientist, she also helps industries and scientists better communicate complex scientific ideas. Her work includes research on small kinase inhibitors at Origenis GmbH and on polymer additives characterization at the Laboratory of Macromolecules and Organic Materials. Currently, she is completing her Master’s thesis in protein design at the Laboratory of Biomolecular Modeling, and plans to continue her academic journey by pursuing a PhD in drug design.</p><p><a href="https://www.linkedin.com/in/alexandrabanbanaste/">https://www.linkedin.com/in/alexandrabanbanaste/</a></p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Zjc75SgL6-Q6gu3QceKOKg.jpeg" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">p3.illustration Official: Instagram, Twitter | Linktree</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3f8a74bd8611" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Osteoblasts]]></title>
            <link>https://sci-illustratestories.medium.com/osteoblasts-26ed438caf77?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/26ed438caf77</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Thu, 28 May 2026 08:25:23 GMT</pubDate>
            <atom:updated>2026-05-28T08:25:23.225Z</atom:updated>
            <content:encoded><![CDATA[<p>Building Bones and Shaping Strength</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*DtNnYgBzcMS6KYUH89tK-w.gif" /></figure><p><em>Credit: Art by Alexandra Banbanaste. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Osteoblasts are the versatile cells responsible for turning genetic blueprints into tangible bone. These matrix-synthesizing cells build the mineralized scaffolding that dictates form, strength, and flexibility to the skeleton after being differentiated from their osteogenic precursors. However, their role is not simply constructional, they are adaptive agents sensitive to structural maintenance and endocrine communication among tissues [1–3].</p><p><strong>Matrix in Motion</strong></p><p>Osteoblasts are tasked with one of biology’s most physically demanding jobs: producing the organic bone matrix. They secrete and produce type I collagen, osteocalcin, alkaline phosphatase, and other proteins that constitute the scaffold for subsequent mineralization. The organic matrix is then calcified to form the rigid tissue required for load bearing, movement, and mineral storage [4–5].</p><p>Osteoblasts are not passive builders, but instead react to the forces placed upon them. Mechanical loading signals osteoblasts by initiating signaling cascades like Wnt/β-catenin and IGF-1, which induce gene expression for the production of matrix and mineral deposition. These dynamic responses ensure that bone architecture is not just maintained, but refined in response to movement, gravity, and stress [6–7].</p><p><strong>Growth on Command</strong></p><p>Hormone signaling is an essential regulator of osteoblast activity, influencing their differentiation, lifespan, and bone-forming capacity. Estrogen, parathyroid hormone (PTH), and vitamin D exert critical control over osteoblast mediated bone formation and turnover. Endocrine imbalances, particularly the decline in estrogen levels with aging, are recognized to accelerate osteoblast apoptosis and dismantle bone upkeep, highlighting the critical role of intricate endocrine regulation of skeletal homeostasis [8–9].</p><p><strong>From Builders to Residents</strong></p><p>Once they finish the matrix production, osteoblasts follow divergent paths. Some undergo apoptosis, while others differentiate into quiescent bone lining cells that cover the bone surface and aid in cell remodeling. A minority seal themselves within the matrix they built, forming osteocytes, the deeply embedded messengers of the bone microenvironment. This transition is critical; osteocytes regulate mineral metabolism and guide osteoblasts and osteoclasts in shaping future remodeling [10].</p><p><strong>Crosstalk in the Remodeling Network</strong></p><p>Osteoblasts are core members of the bone remodeling team. They secrete extracellular regulatory molecules like RANKL and osteoprotegerin (OPG), which control osteoclast formation and function. Through the coordinated regulation of bone resorption and formation, osteoblasts balance bone mass and architecture with systemic needs. Pathology of this crosstalk has been implicated in diseases from osteoporosis to rheumatoid arthritis [11–12].</p><p><strong>Repair and Regeneration</strong></p><p>When the fracture occurs, osteoblasts act as first responders, aiding repair. They migrate to the injury site, where they proliferate, and synthesize extracellular matrix factors to reform the callus that bridges damaged bone. Signaling pathways like BMPs, Notch, and ATF4 are highlighted by studies as key to directing the response and potentially to improving recovery and outcome in regenerative medicine [13–14].</p><p><strong>Bone as a Messenger</strong></p><p>In addition to their structural role, osteoblasts contribute to systemic physiology through their endocrine and metabolic functions. These cells release osteocalcin, a hormone whose surprising systemic function, controlling insulin sensitivity, glucose metabolism, and even brain activity, is just beginning to be unraveled. Emerging evidence positions osteoblasts as endocrine mediators between the skeletal system and distant organs such as the brain, pancreas, and reproductive system [15]. During aging and chronic inflammation, osteoblasts lose their regenerative privilege. Oxidative stress, proinflammatory cytokines secretion, and bone marrow composition changes reduce their numbers and compromise their matrix-forming capabilities. This decline is associated with decreased bone formation, increased susceptibility to fractures, and impaired skeletal response to mechanical loading or injury [16–17].</p><p><strong>Adaptive Builders in a Living Scaffold</strong></p><p>Osteoblasts are not just structural workers; they are decision-making, force-sensing, immune-communicating, and endocrine-communicating cells of a responsive tissue. Their story is one of formation, integration, intelligence, signal responsiveness, and intracellular communication. As we proceed deeper into their varied roles, osteoblasts present as effectors of bone building and as guardians of spinal flexibility.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Zaidi Lab: Icahn School of Medicine at Mount Sinai, New York, NY, USA <a href="https://profiles.mountsinai.org/mone-zaidi">https://profiles.mountsinai.org/mone-zaidi</a> , FB: <a href="https://www.facebook.com/MountSinaiNYC/">https://www.facebook.com/MountSinaiNYC/</a> , LinkedIn: <a href="https://www.linkedin.com/company/mountsinainyc/">https://www.linkedin.com/company/mountsinainyc/</a> , IG: @mountsinainyc , X: @MountSinaiNYC</li><li>Rowe Lab: UConn Health, Farmington, VT, USA <a href="https://bonebase.lab.uconn.edu/person/david-rowe/">https://bonebase.lab.uconn.edu/person/david-rowe/</a></li><li>Kronenburg Lab: <a href="https://www.massgeneral.org/endocrinology/endocrine-unit/research/kronenberg-lab">https://www.massgeneral.org/endocrinology/endocrine-unit/research/kronenberg-lab</a> , FB: <a href="https://www.facebook.com/massgeneral">https://www.facebook.com/massgeneral</a> , LinkedIn: <a href="https://www.linkedin.com/company/massachusetts-general-hospital/">https://www.linkedin.com/company/massachusetts-general-hospital/</a> , IG: @massgeneral , X: @MassGeneralNews</li><li>O’Brien Lab: University of Arkansas for Medical Sciences, Little Rock, AR, USA , <a href="https://ortho.uams.edu/charles-a-obrien-ph-d/">https://ortho.uams.edu/charles-a-obrien-ph-d/</a> , FB: <a href="https://www.facebook.com/UAMShealth/">https://www.facebook.com/UAMShealth/</a> , LinkedIn: <a href="https://www.linkedin.com/school/uams/">https://www.linkedin.com/school/uams/</a> , IG: @uamshealth , X: @uamshealth</li><li>Glimcher Lab: Dana Farber Cancer Institute, Boston, MA, USA <a href="https://www.dana-farber.org/about/leadership/laurie-glimcher">https://www.dana-farber.org/about/leadership/laurie-glimcher</a> , FB: <a href="https://www.facebook.com/danafarbercancerinstitute">https://www.facebook.com/danafarbercancerinstitute</a> , LinkedIn: <a href="https://www.linkedin.com/company/dana-farber-cancer-institute/">https://www.linkedin.com/company/dana-farber-cancer-institute/</a></li><li>Hernandez Lab: UT Southwestern Medical Center, Dallas, TX, USA <a href="https://profiles.utsouthwestern.edu/profile/165681/paula-hernandez.html?_ga=2.131255759.1921282648.1749683081-845498568.1749683081">https://profiles.utsouthwestern.edu/profile/165681/paula-hernandez.html?_ga=2.131255759.1921282648.1749683081-845498568.1749683081</a></li><li>Bonewald Lab: Indiana University School of Medicine, Indianapolis, IN, USA <a href="https://medicine.iu.edu/faculty-labs/bonewald">https://medicine.iu.edu/faculty-labs/bonewald</a></li><li>Bellido Lab: University of Arkansas for Medical Science, Little Rock AR, USA <a href="https://medicine.uams.edu/physiology/faculty/primary-faculty/teresita-bellido-ph-d/bellido-research-laboratory/">https://medicine.uams.edu/physiology/faculty/primary-faculty/teresita-bellido-ph-d/bellido-research-laboratory/</a></li><li>Greenblatt Lab: Weill Cornell Medicine, New York, NY, USA <a href="https://www.thegreenblattlab.com/about">https://www.thegreenblattlab.com/about</a></li><li>Parolini Lab: Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy <a href="https://www.poliambulanza.it/en/doctors/parolini-ornella">https://www.poliambulanza.it/en/doctors/parolini-ornella</a> , FB: <a href="https://www.facebook.com/Poliambulanza">https://www.facebook.com/Poliambulanza</a></li></ol><h4><strong>References</strong></h4><ol><li>Colaianni G, Sun L, Di Benedetto A, et al. Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. <em>J Biol Chem</em>. 2012;287(34):29159–29167.</li><li>Moffatt P, Thomas G, Sellin K, et al. Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth. <em>J Biol Chem</em>. 2007;282(50):36454–36462.</li><li>Kronenberg HM. PTHrP and skeletal development. <em>Ann N Y Acad Sci</em>. 2006;1068:1–13.</li><li>O’Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. <em>Endocrinology</em>. 2004;145(4):1835–1841.</li><li>Jones DC, Wein MN, Glimcher LH. Schnurri-3 is an essential regulator of osteoblast function and adult bone mass. <em>Ann Rheum Dis</em>. 2007;66 Suppl 3(Suppl 3):iii49-iii51.</li><li>Li X, Han L, Nookaew I, et al. Stimulation of Piezo1 by mechanical signals promotes bone anabolism. <em>Elife</em>. 2019;8:e49631.</li><li>Bellido T. Osteocyte-driven bone remodeling. <em>Calcif Tissue Int</em>. 2014;94(1):25–34.</li><li>Xu R, Yallowitz A, Qin A, et al. Targeting skeletal endothelium to ameliorate bone loss. <em>Nat Med</em>. 2018;24(6):823–833.</li><li>Rajpar I, Kumar G, Fortina P, Tomlinson RE. Toll-like receptor 4 signaling in osteoblasts is required for load-induced bone formation in mice. <em>iScience</em>. 2023;26(4):106304.</li><li>Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation via RANKL–RANK–OPG. <em>Nature</em>. 2003;423(6937):337–342.</li><li>Martin TJ, Seeman E. Bone remodelling: its local regulation and the emergence of bone fragility. <em>Best Pract Res Clin Endocrinol Metab</em>. 2008;22(5):701–722.</li><li>Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. <em>Growth Factors</em>. 2004;22(4):233–241.</li><li>Carreira AC, Alves GG, Zambuzzi WF, Sogayar MC, Granjeiro JM. BMPs: structure, biological function, and therapeutic applications. <em>Arch Biochem Biophys</em>. 2014;561:64–73.</li><li>Karsenty G, Oury F. Biology without walls: the novel endocrinology of bone. <em>Annu Rev Physiol</em>. 2012;74:87–105.</li><li>Almeida M, Han L, Martin‑Millan M, et al. Skeletal involution by age-associated oxidative stress and accelerated by sex steroid loss. <em>J Biol Chem</em>. 2007;282(37):27285–27297.</li><li>Wang L, You X, Lotinun S, Zhang L, Wu N, Zou W. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. <em>Nat Commun</em>. 2020;11(1):282.</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/1*9qNUMr_WMIRCjrp3L7Q1WQ.jpeg" /></figure><p><strong>DR. CHRISTY KESTNER<br>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*kM_1eYzYIOYmk2wMkiaFLA.jpeg" /></figure><p><strong>ALEXANDRA BANBANASTE</strong></p><p><strong>Contributing Artist</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Alexandra Banbanaste is completing her Master’s in Chemical Engineering at Ecole Polytechnique Fédérale de Lausanne, where she studied neuroscience, chemistry, and biology.</p><p>Apart from being a passionate scientist, she also helps industries and scientists better communicate complex scientific ideas. Her work includes research on small kinase inhibitors at Origenis GmbH and on polymer additives characterization at the Laboratory of Macromolecules and Organic Materials. Currently, she is completing her Master’s thesis in protein design at the Laboratory of Biomolecular Modeling, and plans to continue her academic journey by pursuing a PhD in drug design.</p><p><a href="https://www.linkedin.com/in/alexandrabanbanaste/">https://www.linkedin.com/in/alexandrabanbanaste/</a></p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Zjc75SgL6-Q6gu3QceKOKg.jpeg" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">https://linktr.ee/p3.illustration</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=26ed438caf77" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Osteogenic Cells]]></title>
            <link>https://sci-illustratestories.medium.com/osteogenic-cells-4380cbabe5e8?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/4380cbabe5e8</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Wed, 15 Apr 2026 21:36:09 GMT</pubDate>
            <atom:updated>2026-04-15T21:36:09.752Z</atom:updated>
            <content:encoded><![CDATA[<p>Fueling Formation and Healing Fractures</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*1nf6FlEYCjBtLLVj4TLJNw.gif" /></figure><p><em>Credit: Art by Alexandra Banbanaste. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Osteogenic cells are the master architects of the skeleton. These stem-like progenitors differentiate into osteoblasts, the bone builders. Concealed in the periosteum, endosteum, and bone marrow, they are the underappreciated starting point of all skeletal remodeling and regeneration. Quiet in quiescence, they burst into action when bone is injured, stressed, or developing; initiating waves of differentiation and matrix synthesis essential to skeletal health.</p><p>Where once they were passive precursors, osteogenic cells are now regarded as highly responsive coordinators of bone homeostasis. They analyze and integrate hormonal, mechanical, and molecular signals to drive osteoblastogenesis. Recent advances in molecular biology, lineage tracing, and single-cell transcriptomics have revealed these cells as dynamic participants in both bone formation and repair [1–3]. From their role in orthopedic regeneration to waning in skeletal aging, osteogenic cells are the focal point for both basic biology and translational innovation.</p><p><strong>The Bone Blueprint</strong></p><p>Typically derived from the mesenchymal lineage, osteogenic cells reside along bone-lining surfaces and within marrow niches. These cells have transcription factors such as Runx2 and Osterix (Sp7) to induce osteoblast differentiation once they receive signals such as Bone Morphogenic Proteins (BMPs), Wnt/β-catenin, and mechanical stress [4–6].</p><p>New evidence indicates that β-catenin activity is important for osteogenic commitment, cortical bone mass, and mechanical strength. Mechanical loading has been demonstrated to induce osteogenic gene expression, matrix deposition, and bone mass by these signaling pathways [7]. Aging, by contrast, drains the density and responsiveness of osteogenic progenitors, although interventions like caloric restriction and manipulation of IGF-1 have been demonstrated to partially restore their function [8–9]. Single-cell analyses have also defined transitional progenitor states of the osteogenic continuum, which underlie understanding individual variation in regenerative ability [10].</p><p><strong>Metabolic Mediators and Matrix Engineers</strong></p><p>Once differentiated, osteogenic cells become osteoblasts, bone matrix-building dynamos that synthesize and secrete the organic components of bone-like type I collagen, osteocalcin, and alkaline phosphatase [4]. This extracellular matrix is subsequently mineralized to form hydroxyapatite crystals, the rigid structure essential for skeletal integrity. Prior to this mineralization phase, osteogenic cells exhibit metabolic activity that functions in nutrient sensing and energy regulation during early differentiation.</p><p>A growing body of evidence suggests that osteogenic differentiation is associated with metabolic reprogramming. Glycolysis, oxidative phosphorylation, and glutamine metabolism are regulated dynamically as the cell transitions from progenitor to matrix-producing cell [11]. Dysregulation of these pathways due to aging, inflammation, or metabolic disease can impair bone development and systemic metabolic regulation.</p><p>Along with structural upkeep, osteogenic cells have a role in endocrine messaging. Osteocalcin-secreting osteoblast-lineage cells contribute to glucose balance and fertility, indicating the endocrine cross-talk of bone with other systems [12]. This metabolic function illuminates the skeletal system’s new definition as not just structural, but regulatory and responsive.</p><p>Bone matrix production is also controlled by environmental signals, including mechanical loading and hypoxia, which alter the metabolic landscape of the osteogenic niche. During stress, osteogenic cells increase the expression of matrix-related genes and initiate survival pathways so that bone development or repair is maintained [13].</p><p><strong>The BoneKeepers of Immunity</strong></p><p>Bone is not just a mineralized scaffold, it’s an active organ in the intersection of immunity and regeneration. There are osteogenic cells in a niche exceedingly interspersed with hematopoietic and immune cells, and their behaviors are essential to skeletal homeostasis.</p><p>Osteogenic progenitors are responsive to, and assist in modulating local immunological signals. Proinflammatory cytokines TNF-α, IL-1β, and IL-6 suppress osteogenic differentiation and increase bone resorption by enhancing osteoclast activity [14]. Chronic inflammation due to autoimmune disease, obesity, or aging can disrupt osteogenesis and force the balance towards bone loss.</p><p>Conversely, osteogenic cells themselves control immune activity. They secrete anti-inflammatory growth factors and immune cell invasion-suppressing molecules. Immunomodulatory activity is most essential in bone grafts and tissue-engineered scaffolds, where immune compatibility will determine if a graft will integrate or deteriorate [15].</p><p>Osteogenic cells have also been shown recently to talk directly to macrophages and T cells and orchestrate the inflammatory stage of fracture repair. Osteoprogenitors bear MHC class I and II molecules and are able to act as non-professional antigen-presenting cells, a function which is currently being explored [16]. This immunocompetence positions osteogenic cells as both bone architects and sentinels of bone integrity.</p><p><strong>Behind the Bonework</strong></p><p>From latent niches to fracture sites, osteogenic cells quietly govern the fate of our bones. Once dismissed as silent precursors, they are now recognized as multitasking engineers, constructors, metabolic regulators, and guardians of immune balance. Their ability to adapt, communicate, and coordinate complex regenerative processes places them at the epicenter of skeletal innovation and age-related research. As science continues to unravel their hidden layers, osteogenic cells emerge not just as blueprints of bone formation, but as its architects, protectors, and storytellers in the evolution of skeletal health.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Civitelli Lab: Washington University in St Louis, MO, USA. <a href="https://bonehealth.wustl.edu/research/laboratories/civitelli-lab/">https://bonehealth.wustl.edu/research/laboratories/civitelli-lab/</a> , FB: <a href="https://www.facebook.com/WashUMedBMD/">https://www.facebook.com/WashUMedBMD/</a> , LinkedIn: <a href="https://www.linkedin.com/company/washumedbmd/">https://www.linkedin.com/company/washumedbmd/</a> , X: @WashUMedBMD</li><li>Clifford Rosen Lab: Maine Health Institute for Research, ME, USA <a href="https://mhir.org/center-for-molecular-medicine/labs-staff/cliff-rosen-md-lab/">https://mhir.org/center-for-molecular-medicine/labs-staff/cliff-rosen-md-lab/</a> ; FB: <a href="https://www.facebook.com/people/MaineHealth-Institute-for-Research/61556247334648/">https://www.facebook.com/people/MaineHealth-Institute-for-Research/61556247334648/</a> ; LinkedIn: <a href="https://www.linkedin.com/company/mainehealth-institute-for-research/">https://www.linkedin.com/company/mainehealth-institute-for-research/</a> ; IG: @mhinstituteforresearch</li><li>Wu Lab: Stanford University, Palo Alto, CA, USA <a href="https://med.stanford.edu/content/sm/joywulab.html">https://med.stanford.edu/content/sm/joywulab.html</a> ; FB: <a href="https://www.facebook.com/stanfordmedicine">https://www.facebook.com/stanfordmedicine</a> ; X: @standfordmed</li><li>Robey Lab: NIH/NIDCR, Bethesda, MD, USA <a href="https://www.nidcr.nih.gov/research/conducted-at-nidcr/investigators/pamela-robey">https://www.nidcr.nih.gov/research/conducted-at-nidcr/investigators/pamela-robey</a></li><li>Rubin Lab: UNC McAllister Heart Institute, Chapel Hill, NC, USA <a href="https://www.med.unc.edu/mhi/laboratories/rubin-lab/">https://www.med.unc.edu/mhi/laboratories/rubin-lab/</a> ; FB: <a href="https://www.facebook.com/uncmcallisterheart/">https://www.facebook.com/uncmcallisterheart/</a> ; IG: @uncmcallister ; X: @UNC_MHI</li><li>Olsen Lab: Harvard School of Dental Medicine, Boston, MA, USA <a href="https://www.hsdm.harvard.edu/people/bjorn-olsen">https://www.hsdm.harvard.edu/people/bjorn-olsen</a> ; FB: <a href="https://www.facebook.com/HarvardDentalMedicine/">https://www.facebook.com/HarvardDentalMedicine/</a> ; LinkedIn: <a href="https://www.linkedin.com/school/harvard-school-of-dental-medicine/">https://www.linkedin.com/school/harvard-school-of-dental-medicine/</a> ; IG: @harvarddentalmed</li><li>Lee Lab: Baylor School of Medicine, Houston, TX, USA <a href="https://www.bcm.edu/research/faculty-labs/brendan-lee-lab">https://www.bcm.edu/research/faculty-labs/brendan-lee-lab</a> ; FB: <a href="https://www.facebook.com/BaylorCollegeOfMedicine">https://www.facebook.com/BaylorCollegeOfMedicine</a> ; LinkedIn: <a href="https://www.linkedin.com/school/baylor-college-of-medicine/">https://www.linkedin.com/school/baylor-college-of-medicine/</a> ; IG: @bcmhouston ; X: @bcmhouston</li><li>Cao Lab: Johns Hopkins School of Medicine, Baltimore, MD, USA <a href="https://profiles.hopkinsmedicine.org/provider/xu-cao/2777874#profile-about">https://profiles.hopkinsmedicine.org/provider/xu-cao/2777874#profile-about</a> ; FB: <a href="https://www.facebook.com/Johns.Hopkins.Medicine">https://www.facebook.com/Johns.Hopkins.Medicine</a> ; LinkedIn: <a href="https://www.linkedin.com/company/johns-hopkins-medicine/">https://www.linkedin.com/company/johns-hopkins-medicine/</a> ; IG: @HopkinsMedicine ; X: @HopkinsMedicine</li><li>Vicki Rosen Lab: Harvard School of Dental Medicine, Boston, MA, USA ; <a href="https://www.hsdm.harvard.edu/people/vicki-rosen">https://www.hsdm.harvard.edu/people/vicki-rosen</a> ; FB: <a href="https://www.facebook.com/HarvardDentalMedicine/">https://www.facebook.com/HarvardDentalMedicine/</a> ; LinkedIn: <a href="https://www.linkedin.com/school/harvard-school-of-dental-medicine/">https://www.linkedin.com/school/harvard-school-of-dental-medicine/</a> ; IG: @harvarddentalmed</li><li>Kacena Lab: Indiana University School of Medicine, Indianapolis, IN, USA <a href="https://medicine.iu.edu/faculty-labs/kacena">https://medicine.iu.edu/faculty-labs/kacena</a> ; FB: <a href="https://www.facebook.com/IUMedicine">https://www.facebook.com/IUMedicine</a> ; LinkedIn: <a href="https://www.linkedin.com/school/indiana-university-school-of-medicine/">https://www.linkedin.com/school/indiana-university-school-of-medicine/</a> ; IG: @iumedschool ; X: @iumedschool</li></ol><h4><strong>References</strong></h4><ol><li>Chen Y, Fan Q, Zhang H, et al. Lineage tracing of cells expressing the ciliary gene IFT140 during bone development. <em>Dev Dyn</em>. 2021;250(4):574–583. doi:10.1002/dvdy.266</li><li>Mo C, Guo J, Qin J, et al. Single-cell transcriptomics of LepR-positive skeletal cells reveals heterogeneous stress-dependent stem and progenitor pools. <em>EMBO J</em>. 2022;41(4):e108415. doi:10.15252/embj.2021108415</li><li>Onodera S, Saito A, Hojo H, et al. Hedgehog Activation Regulates Human Osteoblastogenesis. <em>Stem Cell Reports</em>. 2020;15(1):125–139. doi:10.1016/j.stemcr.2020.05.008</li><li>Salazar VS, Mbalaviele G, Civitelli R. The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity. <em>J Cell Biochem</em>. 2008;104(3):942–952.</li><li>Zhang R, Oyajobi BO, Harris SE, et al. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. <em>Bone</em>. 2013;52(1):145–156.</li><li>Mbalaviele G, Sheikh S, Stains JP, et al. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. <em>J Cell Biochem</em>. 2005;94(2):403–418.</li><li>Zhu H, Su Y, Wang J, Wu JY. The role of vesicle trafficking genes in osteoblast differentiation and function. <em>Sci Rep</em>. 2023;13(1):16079.</li><li>Liu L, Rosen CJ. New insights into calorie restriction-induced bone loss. <em>Endocrinol Metab (Seoul)</em>. 2023;38(2):203–213.</li><li>Devlin MJ, Brooks DJ, Conlon C, et al. Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice. <em>J Endocrinol</em>. 2016;229(3):295–306.</li><li>Kidwai F, Mui BWH, Arora D, et al. Lineage-specific differentiation of osteogenic progenitors from pluripotent stem cells reveals the FGF1-RUNX2 association in neural crest-derived osteoprogenitors. <em>Stem Cells</em>. 2020;38(9):1107–1123.</li><li>Gadomski SJ, Mui BWH, Gorodetsky R, et al. Time‑ and cell‑specific activation of BMP signaling restrains chondrocyte hypertrophy. <em>iScience</em>. 2024;27(8):110537.</li><li>Liu Y, Berendsen AD, Jia S, et al. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. <em>J Clin Invest</em>. 2012;122(9):3101–3113.</li><li>Rubin J, Rubin C, Jacobs CR. Molecular pathways mediating mechanical signaling in bone. <em>Gene</em>. 2006;367:1–16.</li><li>Hu B, Lv X, Chen H, et al. Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones. <em>J Clin Invest</em>. 2020;130(7):3483–3498.</li><li>Zhu S, Bennett S, Kuek V, et al. Endothelial cells produce angiocrine factors to regulate bone and cartilage via versatile mechanisms. <em>Theranostics</em>. 2020;10(13):5957–5965.</li><li>Phillips MD, Kuznetsov SA, Cherman N, et al. Directed differentiation of human induced pluripotent stem cells toward bone and cartilage: in vitro versus in vivo assays. <em>Stem Cells Transl Med</em>. 2014;3(7):867–878.</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/1*9qNUMr_WMIRCjrp3L7Q1WQ.jpeg" /></figure><p><strong>DR. CHRISTY KESTNER<br>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h3>About the artist:</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*kM_1eYzYIOYmk2wMkiaFLA.jpeg" /></figure><p><strong>ALEXANDRA BANBANASTE</strong></p><p><strong>Contributing Artist</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Alexandra Banbanaste is completing her Master’s in Chemical Engineering at Ecole Polytechnique Fédérale de Lausanne, where she studied neuroscience, chemistry, and biology.</p><p>Apart from being a passionate scientist, she also helps industries and scientists better communicate complex scientific ideas. Her work includes research on small kinase inhibitors at Origenis GmbH and on polymer additives characterization at the Laboratory of Macromolecules and Organic Materials. Currently, she is completing her Master’s thesis in protein design at the Laboratory of Biomolecular Modeling, and plans to continue her academic journey by pursuing a PhD in drug design.</p><p><a href="https://www.linkedin.com/in/alexandrabanbanaste/">https://www.linkedin.com/in/alexandrabanbanaste/</a></p><h3>About the animator:</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Zjc75SgL6-Q6gu3QceKOKg.jpeg" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">p3.illustration Official: Instagram, Twitter | Linktree</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4380cbabe5e8" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Urothelial Cells]]></title>
            <link>https://sci-illustratestories.medium.com/urothelial-cells-04b5cd10ad0f?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/04b5cd10ad0f</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Wed, 25 Feb 2026 21:59:16 GMT</pubDate>
            <atom:updated>2026-02-25T21:59:16.025Z</atom:updated>
            <content:encoded><![CDATA[<p><strong><em>Taking on a voluminous challenge</em></strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*DqhL-o9UAyYZk2GMIC7AxQ.gif" /></figure><p><em>Credit: Art by Bruna Di Giacomo. Set in motion by Dr. Emanuele Petretto. Words by Semeli Platsaki, PhD. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p><strong>Lining the urinary tract</strong></p><p>Have you ever had a UTI? An urinary tract infection that is..? Ouch. As the term suggests, UTI impacts the urinary tract, including all urinary organs: the kidneys, which filter your blood, the ureters that connect the kidneys to the bladder, which holds urine and, finally, the urethra, through which urine is ejected from the body (1, 2). The urinary tract is lined by the urothelium, an epithelial tissue enabling the bladder to expand and contract, depending on its content, while acting as a barrier to protect the internal tissues (vascular, muscular, nervous) from the toxic or pathogenic contents of the urinary tract (2). When the urothelium gets colonised by uropathogenic bacteria (Escherichia coli most often), we are in trouble!</p><p><strong>Shapes and sizes</strong></p><p>As we ‘traverse’ the epithelial tissue from the basolateral membrane towards the lumen, we encounter three types of urothelial cells, with increasing size: basal, intermediate and umbrella cells, respectively (1). Basal cells, cuboidal in shape and the smallest in size, are located closest to the internal parts of the body (muscles, blood vessels, etc.). They are the least differentiated cells of the three. Intermediate cells, bigger in size than basal cells, are arranged in multiple layers, the number of which depends on the bladder content. Fewer layers of intermediate cells are observed when the bladder is full, and the layers have been hypothesized to slide against one another while cell contacts are maintained (1). Finally, umbrella cells are fully differentiated, hexagonal, and the largest of the three. They can change their form from dome-shaped (hence the name ‘umbrella’) to flat as the bladder fills up with urine (1, 2). A thin glycoprotein layer, the glycocalyx, coats the apical membrane of umbrella cells on the lumen side and is thought to have anti-adherent properties, thus generating an additional defence against pathogens. While in homeostasis, the urothelium remains rather unchangeable, whereas situations like injury can induce activation of regeneration and repair mechanisms. The basal layer of urothelial cells acts as a reserve of stem cells that serve in regeneration (1, 3–4).</p><p><strong>Setting the limits</strong></p><p>As a layer of the urinary tract, the urothelium has to be one of the most impenetrable epithelial barriers of the body in order to protect it from excess water, ions, soluble molecules, metabolic waste and, of course, pathogens (1). And all this, while still resisting high mechanical, chemical, osmotic and hydrostatic pressure changes linked to urine production, storage and ejection.</p><p>The umbrella cells, interconnected through the Apical Junctional complex (AJC), are critical in this barrier role (5). The AJC controls the entry of ions and soluble molecules in the paracellular space and is composed of three types of connections: tight junctions (TJs), adherens junctions and desmosomes. Tight junctions, formed by the members of the claudin and occludin protein families, separate the apical and basal membranes while acting as gates to the paracellular space. TJs are responsible for sealing the urothelium against urine (6). The exact combination of claudin protein variants regulates the open versus closed (barrier) conformation of a TJ (7–8). Another protein family, uroplakins, form a structured crystalline layer (the unique asymmetric unit) on the apical membrane of umbrella cells, contributing to sealing the urothelium (2, 3). Adherens junctions and desmosomes connect the intercellular space with the umbrella cell cytoskeleton microfilaments. The urothelium has to adapt to the function of the urinary system, meaning the filling and voiding of the bladder. As a result, the urothelium barrier function is a dynamic process. An increase in vesicle trafficking by endo- and exocytosis enables the urothelium to expand through the increase of the apical membrane surface of umbrella cells during the filling of the bladder (9–10). It is through this dynamic adaptation process that urothelial cells maintain their barrier function despite the changing volume of the bladder.</p><p><strong>I need to pee!</strong></p><p>The barrier function of the urothelium is not only necessary for the protection of the body from urine contents; it is also needed for functional signalling from the urinary tract to the central nervous system (2). The urothelium receives and transmits mechanical and chemical signals. In the case of a full bladder, the pressure of the urine and change in the volume of the bladder induce mechanical tension to the urothelium, which prompts micturition, in other words, the emptying of the bladder, through signaling to bladder nerve cells (11–13). Urothelial cells express numerous receptors and ion channels (such as acid-sensing ion channels) which secrete a number of signalling molecules, including neurotrophins, neuropeptides, ATP, acetylcholine, prostaglandins, nitric oxide, and cytokines that, in turn, regulate the function of sensory neurons (2). ATP, released either by exocytosis or through ATP-binding cassette transporters from both the apical and basolateral membranes of the urothelium, is the main messenger molecule released by urothelial cells in purinergic mechanosensory transduction to signal that the bladder is full (14).</p><p><strong>Urothelium under pressure</strong></p><p>Stress, whether physical or psychological, can alter the ability of urothelial cells to maintain an intact barrier against the environment. Changes in the proteoglycan composition of the glycocalyx layer, normally preventing bacterial adhesion to urothelium, can have the opposite result, facilitating attachment of pathogens to umbrella cells. For example, overexpression of uroplakin III can result in infection of urothelial cells by E. coli (15). The internalisation of the bacterium is the first step for forming colonies inside umbrella cells, subsequently leading to recurrent urinary tract infections (2). In addition, a compromised urothelium leads to sensory dysfunction resulting in conditions such as bladder pain syndrome or overactive bladder (16, 17). While ATP is considered to play a role in disorders of the lower urinary tract, the exact mechanisms by which it regulates urinating is not yet understood (2).</p><p><strong>The C word</strong></p><p>An inevitable result of urothelial cell exposure to toxic substances contained in urine is the accumulation of DNA mutations. The evolution of urothelial cell cancer is known to follow two pathways, ‘papillary non-invasive’ versus ‘flat invasive’ cancer, depending on the gene affected (18). Benign papillomas are a typical example of a non-invasive tumor that is contained in the urothelium, as these tumors are limited in their capacity to grow and spread. Although mutations are not sufficient to cause cancer, they are thought to be responsible for what is called the ‘field effect’: a mutational background that favours recurrent local cell abnormalities. On the other hand, invasive urothelial cancers may result either from the (rare) evolution of a non-invasive type or from a new mutation that causes a ‘flat invasive’ cell profile, enabling the cancerous cells to spread to the muscle tissues outside the urothelium (18). These types of cancer are far more aggressive and often progress and metastasise lethally.</p><p>It is hypothesized that the high proliferative capacity of basal cells (the least differentiated of the three types of urothelial cells) is phenotypically similar to invasive carcinomas and linked to their capacity to recur. Interestingly, the protective mechanisms that naturally exist in stem cells are also present in their cancerous counterparts (cancer stem cells), making them resistant to chemotherapy. In that sense, urothelial basal-like cancerous stem cells have been related to carcinoma invasiveness and recurrence and are now considered a promising direction for future research on the treatment of invasive urothelial carcinoma.</p><h4>Recognizing and appreciating the labs working in this space:</h4><ul><li>Jenniffer Rohn Group, College London, Department of Renal Medicine, Division of Medicine, London, UK, <a href="https://profiles.ucl.ac.uk/6235-jennifer-rohn">https://profiles.ucl.ac.uk/6235-jennifer-rohn</a>, X: @JennyRohn</li><li>Cathy Lee Mendelsohn, Columbia University, Department of Pathology and Cell Biology, New York, USA, <a href="https://www.pathology.columbia.edu/profile/cathy-l-mendelsohn-phd">https://www.pathology.columbia.edu/profile/cathy-l-mendelsohn-phd</a>, X: @cathyleemendel</li><li>Apodaca Lab, Research in Epithelial Cell Biology, University of Pittsburgh, PA, USA, Renal/Electrolyte division, <a href="https://apodaca2.dept-med.pitt.edu/">https://apodaca2.dept-med.pitt.edu/</a></li><li>Laboratory of Mucosal Barrier Pathobiology, Harvard Medical School, Boston, MA, USA, <a href="https://jrturnerlab.com/">https://jrturnerlab.com/</a>, X: @JerroldTurner6</li><li>Yuanyuan Zhang Lab, Wake Forest University School of Medicine, Institute for Regenerative Medicine, Winston-Salem, NC, USA. <a href="https://school.wakehealth.edu/faculty/z/yuanyuan-zhang">https://school.wakehealth.edu/faculty/z/yuanyuan-zhang</a></li><li>Soman Abraham Group, Duke University, School of Medicine, North Carolina, NC, USA, <a href="https://medschool.duke.edu/profile/soman-ninan-abraham">https://medschool.duke.edu/profile/soman-ninan-abraham</a></li><li>David Klumpp Group, Northwestern University, Feinberg School of Medicine, Evanston , IL USA, <a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=11790">https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=11790</a></li><li>Wouter Everaerts, Laboratory of Ion Channel Research, VIB-KU Leuven, Belgium, <a href="https://www.kuleuven.be/wieiswie/en/person/00041047">https://www.kuleuven.be/wieiswie/en/person/00041047</a>, X: @EveraertsW</li><li>Berman Lab, Queen’s University, Kingston, Ontario, Canada, <a href="https://bermanlab.org/index.html">https://bermanlab.org/index.html</a></li></ul><h4><strong>References</strong></h4><ol><li>Jafari, Nazila V, and Jennifer L Rohn. “The urothelium: a multi-faceted barrier against a harsh environment.” <em>Mucosal immunology</em> vol. 15,6 (2022): 1127–1142. doi:10.1038/s41385–022–00565–0</li><li>Birder, Lori, and Karl-Erik Andersson. “Urothelial signaling.” <em>Physiological reviews</em> vol. 93,2 (2013): 653–80. doi:10.1152/physrev.00030.2012</li><li>Hicks, R M. “The mammalian urinary bladder: an accommodating organ.” <em>Biological reviews of the Cambridge Philosophical Society</em> vol. 50,2 (1975): 215–46. doi:10.1111/j.1469–185x.1975.tb01057.x</li><li>Gandhi, Devangini et al. “Retinoid signaling in progenitors controls specification and regeneration of the urothelium.” <em>Developmental cell</em> vol. 26,5 (2013): 469–482. doi:10.1016/j.devcel.2013.07.017</li><li>Garcia, Miguel A et al. “Cell-Cell Junctions Organize Structural and Signaling Networks.” <em>Cold Spring Harbor perspectives in biology</em> vol. 10,4 a029181. 2 Apr. 2018, doi:10.1101/cshperspect.a029181</li><li>Shashikanth, Nitesh et al. “Epithelial Organization: The Gut and Beyond.” <em>Comprehensive Physiology</em> vol. 7,4 1497–1518. 12 Sep. 2017, doi:10.1002/cphy.c170003</li><li>Van Itallie, Christina M, and James M Anderson. “Claudins and epithelial paracellular transport.” <em>Annual review of physiology</em> vol. 68 (2006): 403–29. doi:10.1146/annurev.physiol.68.040104.131404</li><li>Anderson, James M, and Christina M Van Itallie. “Physiology and function of the tight junction.” <em>Cold Spring Harbor perspectives in biology</em> vol. 1,2 (2009): a002584. doi:10.1101/cshperspect.a002584</li><li>Khandelwal, Puneet et al. “Rab11a-dependent exocytosis of discoidal/fusiform vesicles in bladder umbrella cells.” <em>Proceedings of the National Academy of Sciences of the United States of America</em> vol. 105,41 (2008): 15773–8. doi:10.1073/pnas.0805636105</li><li>Truschel, Steven T et al. “Stretch-regulated exocytosis/endocytosis in bladder umbrella cells.” <em>Molecular biology of the cell</em> vol. 13,3 (2002): 830–46. doi:10.1091/mbc.01–09–0435</li><li>Birder, Lori et al. “Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat.” <em>The Journal of pharmacology and experimental therapeutics</em> vol. 323,1 (2007): 227–35. doi:10.1124/jpet.107.125435</li><li>Birder, L A et al. “Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1.” <em>Nature neuroscience</em> vol. 5,9 (2002): 856–60. doi:10.1038/nn902</li><li>Bishop, Brian L et al. “Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.” <em>Nature medicine</em> vol. 13,5 (2007): 625–30. doi:10.1038/nm1572</li><li>Burnstock, G. “Purinergic signalling in the lower urinary tract.” <em>Acta physiologica (Oxford, England)</em> vol. 207,1 (2013): 40–52. doi:10.1111/apha.12012</li><li>Thumbikat, Praveen et al. “Bacteria-induced uroplakin signaling mediates bladder response to infection.” <em>PLoS pathogens</em> vol. 5,5 (2009): e1000415. doi:10.1371/journal.ppat.1000415</li><li>Everaerts, Wouter et al. “On the origin of bladder sensing: Tr(i)ps in urology.” <em>Neurourology and urodynamics</em> vol. 27,4 (2008): 264–73. doi:10.1002/nau.20511</li><li>Nilius, Bernd et al. “Transient receptor potential cation channels in disease.” <em>Physiological reviews</em> vol. 87,1 (2007): 165–217. doi:10.1152/physrev.00021.2006</li><li>Brandt, William D et al. “Urothelial carcinoma: stem cells on the edge.” <em>Cancer metastasis reviews</em> vol. 28,3–4 (2009): 291–304. doi:10.1007/s10555–009–9187–6</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*OvH0IZ9tZ5MuEoljmrao6g.jpeg" /></figure><p><strong>DR. SEMELI PLATSAKI</strong></p><p><strong>Content Editor </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Semeli is a biochemist at heart, holding a degree in Chemistry and a PhD in protein biochemistry. After working as a researcher studying the structure-function relationship of proteins in a range of biological contexts, from bacterial metalloproteins to synaptic signaling, Semeli moved on to a role in Scientific communication and project management in the European Virus Archive, a collection of virus and virus-derived resources available to researchers worldwide. Semeli is passionate about the creative mix of art, words and science, one of the best ways to make Science impactful.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*e9pt5JvJ7aogqKUtw_-Q9g.jpeg" /></figure><p><strong>DR. BRUNA DI GIACOMO</strong></p><p><strong>Contributing Artist </strong>The League of Extraordinary Celltypes, Sci-Illustrate Stories</p><p>Bruna received her Bachelor’s degree in Biological Sciences and her Master’s in Cellular and Molecular Biology from the University of Tuscia, Italy. She then pursued a PhD in Molecular Biology at the Max Planck Institute for Biology of Aging in Cologne, Germany.</p><p>Alongside her scientific career, she has nurtured a passion for the arts, exploring various crafts as hobbies, such as sculpture, embroidery, and digital drawing. These combined interests led her to create scientific graphics, and to use illustrations as a tool to communicate biology in a simpler and more accessible way.</p><p>Currently residing in Germany, Bruna continues to illustrate scientific concepts, with a particular focus on cover illustrations, some of which have been published in esteemed scientific journals.</p><p>LinkedIn: <a href="http://www.linkedin.com/in/brunadigiacomo">www.linkedin.com/in/brunadigiacomo</a></p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Zjc75SgL6-Q6gu3QceKOKg.jpeg" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">p3.illustration Official: Instagram, Twitter | Linktree</a></p><h4>About the series:</h4><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=04b5cd10ad0f" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Leydig Cells]]></title>
            <link>https://sci-illustratestories.medium.com/leydig-cells-75851c676938?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/75851c676938</guid>
            <category><![CDATA[fertility]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Sun, 08 Feb 2026 17:36:18 GMT</pubDate>
            <atom:updated>2026-02-08T17:36:18.382Z</atom:updated>
            <content:encoded><![CDATA[<h4>The Secret Makers of Testosterone</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*SunJHlmRG8Bga__3UlielA.gif" /></figure><p><em>Credit: Art by Bruna Di Giacomo. Set in motion by Dr. Emanuele Petretto. Words by Dr. Akanksha Gandhi. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a><em> </em><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p><strong>A Brief History of Discovery</strong></p><p>Leydig cells, which were first identified in 1850 by German scientist Franz von Leydig, are hormone-secreting cells found in the testes [1, 2]. Also referred to as interstitial cells of the testes or interstitial cells of Leydig, they play a crucial role in male reproductive physiology. In the early 1900s, researchers discovered that these cells secrete androgens — hormones vital to male sexual development [3]. Over the next few decades, scientists elucidated the ways in which Leydig cells function: they contain key enzymes involved in hormone synthesis and respond to cues from the pituitary gland [4]. By 1969, they were known to convert cholesterol into testosterone [5]. It then took more than a century to piece together how these tiny cells fuel male hormone production.</p><p><strong>Unique Features</strong></p><p>When scientists examined Leydig cells, under an electron microscope, they discovered that they occur in small strands that are referred to as cords. These cells are enveloped by a very fine common layer referred to as the basal lamina, which serves to anchor them [6]. Situated within the interstitial tissue between the sperm-producing tubules of the testes, these hormone-secreting cells are arranged in small clusters closely associated with blood and lymphatic vessels. They are polygonal in shape and appear pink when stained, due to their eosinophilic properties in immunohistochemistry. They contain large rounded nuclei and are abundant in lipids and energy-producing structures such as mitochondria. Leydig cells are very specialized for hormone synthesis, particularly testosterone. They contain smooth endoplasmic reticulum and unique features like lipofuscin (waste from lipid metabolism) and Reinke crystals. These are rod-like structures that are present exclusively in these cells, but their function is not known [7,8].</p><p><strong>Small Cells, Big Impact</strong></p><p>Have you ever wondered what really drives male puberty, muscle growth, and all those transformations that help a boy become a man? Well, it all comes down to testosterone, which is produced in these cells after getting instructions from the brain via a chemical messenger known as luteinizing hormone. This hormone does more than just help with muscle and voice changes; it’s vital for sperm production, steering sexual development, and preserving male traits and behaviors throughout life. So, even though Leydig cells are small, they are responsible for some of the most significant changes in the male body [9].</p><p><strong>The Two Lives of Leydig Cells</strong></p><p>Leydig cells originate from a pool of stem or progenitor cells located in the interstitial compartment of the testes. These precursor cells differentiate through a tightly regulated developmental process. The first generation, known as <strong>fetal Leydig cells</strong>, begin their work before birth and can be identified by the presence of projections called primary cilia (tiny protrusions of the cell). Fatal Leydig cells cluster together and are encased in a thin layer of cells called basement membrane. They are characterized by having a large smooth endoplasmic reticulum, mitochondria in different shapes, and a lot of fat droplets that serve as building blocks for hormone production [10,11,12]. Leydig cells which are active after puberty are known as<strong> adult Leydig cells</strong>. These also cluster together, but don’t have a basement membrane surrounding them, and they tend to have less fat droplets — which means they still produce testosterone, but in a different quantity. In simple words, fetal Leydig cells function similarly to well-equipped startup labs, whereas adult leydig cells are much more experienced and efficient.</p><p><strong>Leydig Cells in Disease</strong></p><p>Sometimes, Leydig cells can develop into a tumor known as a <strong>leydig cell tumor</strong>. Although this kind of testicular tumor is uncommon, it frequently affects younger men and develops as a painless lump in the testicle [13]. These tumors are typically benign, which means they don’t spread quickly. Rarely, though, they have the ability to spread, or metastasize, to different areas of the body. Interestingly, because of the increased testosterone production, children with Leydig cell tumors may experience precocious puberty, or an early onset of puberty [14].</p><p>Another condition associated with Leydig cells is <strong>Klinefelter syndrome</strong>. Despite having a large number of Leydig cells, people with this syndrome typically have low testosterone levels because their cells aren’t working properly. Additionally, they frequently exhibit hypergonadotropic hypogonadism (when the sex glands fail to secrete enough hormones, despite the brain providing them with very strong stimuli to make them work) or elevated luteinizing hormone levels. Infertility, decreased muscle mass, gynecomastia (male breast tissue enlargement), and either delayed or incomplete puberty are among the several issues that can result from this hormonal imbalance [15].</p><p>Leydig cells have a surprising ability to recover, allowing testosterone production and male reproductive function to continue. Because of this, they offer scientists valuable opportunities to study how cells develop and how hormone levels are regulated — providing important insights into fertility and related health conditions [16].</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Jorgensen Lab: University of Wisconsin School of Veterinary Medicine, Madison, USA <a href="https://www.vetmed.wisc.edu/lab/jorgensen/research/">https://www.vetmed.wisc.edu/lab/jorgensen/research/</a> , X: @JorgensenLab</li><li>Takashi Aoi, Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan <a href="https://www.lab.kobe-u.ac.jp/gmed-ipsc/en/publication/index.html">https://www.lab.kobe-u.ac.jp/gmed-ipsc/en/publication/index.html</a></li><li>Barry Zirkin, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA <a href="https://publichealth.jhu.edu/faculty/788/barry-zirkin">https://publichealth.jhu.edu/faculty/788/barry-zirkin</a></li><li>Molecular and Clinical Endocrinology Lab, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy <a href="https://sites.google.com/uniroma1.it/mcel/">https://sites.google.com/uniroma1.it/mcel/</a></li><li>Klaus-Peter Dieckmann’s Lab, Asklepios Klinik Altona, Hamburg, Germany <a href="https://www.researchgate.net/lab/Klaus-Peter-Dieckmann-Lab">https://www.researchgate.net/lab/Klaus-Peter-Dieckmann-Lab</a></li><li>Barbara Bilinska’s Lab, Department of Endocrinology, Institute of Zoology and Biomedical Research, Jagiellonian University, Krakow, Poland <a href="https://ze.izibb.wb.uj.edu.pl/tematyka-badawcza">https://ze.izibb.wb.uj.edu.pl/tematyka-badawcza</a></li><li>School of Biodiversity, One Health &amp; Veterinary Medicine, Veterinary Research Facility, University of Glasgow, Glasgow, UK <a href="https://www.gla.ac.uk/schools/bohvm/research/about/fundingsummary/2012/possertoli/headline_694800_en.html">https://www.gla.ac.uk/schools/bohvm/research/about/fundingsummary/2012/possertoli/headline_694800_en.html</a></li><li>The Institute for Regeneration and Repair (IRR), Medical Research Council Centre for Reproductive Health, The Queen’s Medical Research Institute, University of Edinburgh, United Kingdom <a href="https://regeneration-repair.ed.ac.uk/">https://regeneration-repair.ed.ac.uk/</a></li><li>Ren-shan Ge’s Lab, Wenzhou Medical College, Wenzhou, Zhejiang 325027, People’s Republic of China <a href="https://www.researchgate.net/lab/Ren-shan-Ge-Lab">https://www.researchgate.net/lab/Ren-shan-Ge-Lab</a></li><li>Laboratory for Reproductive Endocrinology and Signaling, <a href="https://www.researchgate.net/institution/University-of-Novi-Sad?_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6InNjaWVudGlmaWNDb250cmlidXRpb25zIiwicGFnZSI6InByb2ZpbGUifX0">University of Novi Sad</a>, Department of Biology and Ecology, Novi Sad, Serbia <a href="https://wwwold.dbe.pmf.uns.ac.rs/en/nauka-eng/lares">https://wwwold.dbe.pmf.uns.ac.rs/en/nauka-eng/lares</a></li></ol><h4><strong>References</strong></h4><p>1.<strong> </strong>Leydig F. Zur Anatomie der Männlichen Geschlechtsorgane und Analdrüsen der Säugethiere. <em>Z Wiss Zool</em>. 1850; 2: 1–57.</p><p>2. Le Minor JM, Sick H. About the 350th anniversary of the foundation of the chair of anatomy of the faculty of medicine at Strasbourg (1652–2002). Hist Sci Med 2003;37:31–40.</p><p>3. Christensen, A. K., &amp; Mason, N. R. (1965). Comparative ability of seminiferous tubules and interstitial tissue of rat testes to synthesize androgens from progesterone‐4‐14 C in vitro. Endocrinology, 76,646–656.</p><p>4. Baille AH. Further observations on the growth and histochemistry of Leydig tissue in the postnatal prepubertal mouse testis. J Anat 1964;98:403–418.</p><p>5. Hall PF, Irby DC, De Kretser DM. Conversion of cholesterol to androgens by rat testes: comparison of interstitial cells and seminiferous tubules. Endocrinology 1969;84(3):488–496.</p><p>6. Ezeasor DN. Light and electron microscopical observations on the Leydig cells of the scrotal and abdominal testes of naturally unilateral cryptorchid West African dwarf goats. J Anat. 1985 Aug;141:27–40.</p><p>7. Wang JQ, Cao WG. Morphological characterization of adult mouse Leydig cells in culture. Biochem Biophys Res Commun. 2016 Jan 22;469(4):836–41.</p><p>8. Ezeasor DN. Light and electron microscopical observations on the Leydig cells of the scrotal and abdominal testes of naturally unilateral cryptorchid West African dwarf goats. J Anat. 1985 Aug;141:27–40.</p><p>9. Zirkin BR, Papadopoulos V. Leydig cells: formation, function, and regulation. Biol Reprod. 2018 Jul 1;99(1):101–111. doi: 10.1093/biolre/ioy059. PMID: 29566165; PMCID: PMC6044347.</p><p>10. Haider, S. G. (2004). Cell biology of Leydig cells in the testis. International Review of Cytology, 233, 181–241.</p><p>11. Kuopio, T., Paranko, J., &amp; Pelliniemi, L. J. (1989). Basement membrane and epithelial features of fetal‐type Leydig cells in rat and human testis. Differentiation, 40(3), 198–206.</p><p>12. Roosen‐Runge, E. C., &amp; Anderson, D. (1959). The development of the interstitial cells in the testis of the albino rat. Cells Tissues Organs, 37,125–137.</p><p>13. Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol. 1998 Nov;22(11):1361–7. doi: 10.1097/00000478–199811000–00006. PMID: 9808128.</p><p>14. Powari M, Kakkar N, Singh SK, Rai RS, Jogai S. Malignant Leydig cell tumour of the testis. Urol Int. 2002;68(1):63–5. doi: 10.1159/000048420. PMID: 11803271.</p><p>15. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter’s syndrome. Lancet. 2004 Jul 17–23;364(9430):273–83. doi: 10.1016/S0140–6736(04)16678–6. PMID: 15262106.</p><p>16. Sharpe, R.M., Maddocks, S. and Kerr, J.B. (1990), Cell-cell interactions in the control of spermatogenesis as studied using leydig cell destruction and testosterone replacement. Am. J. Anat., 188: 3–20.</p><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*sHocDzpNOKvMLNFP2Mhy6A.jpeg" /></figure><p><strong>Dr. Akanksha Gandhi</strong></p><p><strong>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Akanksha Gandhi earned her PhD in Molecular Biology from the Max Planck Institute for Chemical Ecology in Jena, Germany, in 2024. Prior to that, she completed her Master’s degree in Biology at the University of Texas Rio Grande Valley, USA. Her academic journey has been shaped by a deep curiosity about the natural world and a passion for scientific discovery. Outside the lab, Akanksha enjoys cooking, watching movies, and spending time outdoors, especially going for walks and hiking. She also has a growing interest in science communication and is currently exploring ways to make complex scientific ideas more accessible and engaging to broader audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*e9pt5JvJ7aogqKUtw_-Q9g.jpeg" /></figure><p><strong>BRUNA DI GIACOMO</strong></p><p>Contributing Artist at <em>The League of Extraordinary Celltypes, Sci-Illustrate Stories</em></p><p>Bruna received her Bachelor’s degree in Biological Sciences and her Master’s in Cellular and Molecular Biology from the University of Tuscia, Italy. She then pursued a PhD in Molecular Biology at the Max Planck Institute for Biology of Aging in Cologne, Germany.</p><p>Alongside her scientific career, she has nurtured a passion for the arts, exploring various crafts as hobbies, such as sculpture, embroidery, and digital drawing. These combined interests led her to create scientific graphics, and to use illustrations as a tool to communicate biology in a simpler and more accessible way.</p><p>Currently residing in Germany, Bruna continues to illustrate scientific concepts, with a particular focus on cover illustrations, some of which have been published in esteemed scientific journals.</p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*Zjc75SgL6-Q6gu3QceKOKg.jpeg" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">p3.illustration Official: Instagram, Twitter | Linktree</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=75851c676938" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Adipocyte Fat Cells]]></title>
            <link>https://sci-illustratestories.medium.com/adipocyte-fat-cells-fde65f414ded?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/fde65f414ded</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[science]]></category>
            <category><![CDATA[body]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Thu, 08 Jan 2026 08:35:22 GMT</pubDate>
            <atom:updated>2026-01-08T08:35:22.392Z</atom:updated>
            <content:encoded><![CDATA[<p>The Metabolic Marvels</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*zl_8t-rsrEAU174BV-ruiQ.gif" /></figure><p><em>Credit: Art by Nelli Aghekyan. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Adipocytes, also referred to simply as fat cells, are too frequently misconceived as passive repositories for stored calories. In reality, adipocytes do much more than store fat. These metabolically active cells play central roles in energy balance, thermogenesis, inflammation, and general metabolic regulation. Even the term adipocyte derives from the Latin words adipo (fat) and cyte (cell), which underscores their basic function in the body’s intricate physiological mechanisms. Their influence on metabolic homeostasis is both significant and complex.</p><h4><strong><em>A Posse of Cell Types</em></strong></h4><p>The adipocyte domain is multifaceted, comprising white, brown, and beige types. White adipocytes are energy storage depots of subcutaneous and visceral fat, while brown adipocytes, packed with mitochondria and containing uncoupling protein 1 (UCP-1), generate heat through non-shivering thermogenesis [1]. Beige adipocytes, which occur in white fat stores in response to specific stimuli like cold, combine the features of both white and brown adipocytes, making the body more metabolically flexible [2]. The research postulates that white adipocytes’ ability to switch to beige cells is crucial in controlling obesity and other metabolic disease states [3].</p><h4><strong><em>Turning Fat into Heat</em></strong></h4><p>Thermogenesis, or the production of heat, is primarily controlled by brown and beige adipocytes [4–5]. When activated, these cells use energy and burn calories, thus maintaining body temperature. The molecular controllers of this process, such as PGC-1α and PRDM16, have been extensively researched for their capacity to induce UCP1 expression and mitochondrial activity [6–7]. Recent studies are investigating how to trigger white adipocytes to be transformed into beige adipocytes, which can be of therapeutic use against obesity [6–7].</p><h4><strong><em>Dysfunctional Engines</em></strong></h4><p>Not all fat cells contribute to metabolism. Growth of white adipose tissue, especially visceral fat, results in chronic inflammation and metabolic illness. This type of inflammation is triggered by immune cell activation and cytokines, which results in insulin resistance in organs and the development of type 2 diabetes [8–10]. Experiments have shown that nuclear receptors like PPARγ suppress inflammation in fat tissue and thereby present new options for potential therapies [11–12].</p><h4><strong><em>The Small Cells with Great Impact</em></strong></h4><p>Adipocytes are not fixed. Their ability to adapt, either by altering their function or altering their type, is invaluable in order to maintain the body in balance. For example, during cold, white adipocytes have the ability to transform into beige fat cells, which are thermogenic. This adaptability is important in managing energy levels and coping with metabolic demands. Our greater insight into the signal pathways that govern adipocyte plasticity has opened up new avenues for intervention in obesity and related diseases [13–15].</p><h4><strong><em>New Fat Cells are Generated and Old Ones are Replaced</em></strong></h4><p>Modern science has refuted the long-standing belief that fat cells are inert, and rather, it has been discovered that adipocyte turnover is an ongoing process [16–17]. Diet, exercise, and metabolic well-being all profoundly influence the rate of replacement of fat cells. Turnover rates also vary with the type of fat, with visceral fat being replaced faster than subcutaneous fat [18]. All of this contradicts conventional knowledge regarding fat cell biology and gives a new direction to improve metabolic well-being [19].</p><h4><strong><em>The Metabolic Storm</em></strong></h4><p>Adipocytes play a pivotal role in the pathogenesis of a variety of metabolic diseases, including obesity, type 2 diabetes, and cardiovascular disease [14–15, 20]. Visceral versus subcutaneous fat’s biphasic effects on overall well-being emphasize adipose tissue’s complex nature. By illuminating inter-relationships between adipocyte activity and systemic metabolism, scientists are striving to give targeted therapies to profit from the beneficial properties of brown and beige adipocytes but also to undo the damaging consequences of excess white fat [2, 5, 20–21].</p><p>With ongoing research into adipocytes, the intricate way in which fat cells maintain metabolic health is being uncovered. By tapping into the regenerative and thermogenic ability of these cells, scientists are providing the entry point for revolutionary ways to treat metabolic disease.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Seale Lab: University of Pennsylvania/ Perelman School of Medicine, Philadelphia, PA, USA. <a href="https://www.med.upenn.edu/sealelab/">https://www.med.upenn.edu/sealelab/</a> , X: <a href="https://x.com/labseale?lang=en">@LabSeale</a></li><li>Spiegelman Lab: Harvard Medical School &amp; Dana Farber Cancer Institute. Boston, MA, USA. <a href="https://labs.dana-farber.org/spiegelmanlab/research">https://labs.dana-farber.org/spiegelmanlab/research</a> , X: <a href="https://x.com/labspiegelman?lang=en">@LabSpiegelman</a></li><li>Lazar Lab: University of Pennsylvania, Philadelphia, PA, USA. <a href="https://lazarlabpenn.com/">https://lazarlabpenn.com/</a></li><li>Gupta Lab: UT Southwestern Medical Center, Dallas, TX, USA. <a href="https://touchstonelabs.org/r-gupta-lab">https://touchstonelabs.org/r-gupta-lab</a></li><li>Cohen Lab: The Rockefeller University, New York, NY, USA. <a href="https://cohenlab.rockefeller.edu/">https://cohenlab.rockefeller.edu/</a></li><li>Spalding Lab: Karolinska Institute, Solna, Sweden. <a href="https://www.spaldinglab.org/">https://www.spaldinglab.org/</a> , X: @SpaldingLab</li><li>O’Rourke Lab: University of Michigan Medical School, Ann Arbor, MI, USA. <a href="https://medresearch.umich.edu/labs-departments/research-labs/orourke-lab/research">https://medresearch.umich.edu/labs-departments/research-labs/orourke-lab/</a></li><li>Ferrante Lab: Columbia University, New York, NY, USA. <a href="https://www.ferrantelab.org/">https://www.ferrantelab.org/</a></li><li>Rodeheffer Lab: Yale School of Medicine, New Haven, CT, USA. <a href="https://medicine.yale.edu/lab/rodeheffer/">https://medicine.yale.edu/lab/rodeheffer/</a></li><li>Deplancke Lab: École Polytechnique Fédérale de Lausanne,<strong> </strong>Lausanne, Switzerland. <a href="https://www.epfl.ch/labs/deplanckelab/">https://www.epfl.ch/labs/deplanckelab/</a></li></ol><h4><strong>References</strong></h4><ol><li>Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. <em>Nature</em>. 2012;481(7382):463–468.</li><li>Kajimura S, Seale P, Spiegelman BM. Transcriptional control of brown fat development. <em>Cell Metab</em>. 2010;11(4):257–262.</li><li>Seale P, Bjork B, Yang W, Kajimura S, Spiegelman BM. PRDM16 controls a brown fat/skeletal muscle switch. <em>Nature</em>. 2008;454(7207):961–967.</li><li>Gupta RK, Arany Z, Seale P, et al. Transcriptional control of preadipocyte determination by Zfp423. <em>Nature</em>. 2010;464(7288):619–623.</li><li>Gupta RK, Mepani RJ, Kleiner S, et al. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. <em>Cell Metab</em>. 2012;15(2):230–239.</li><li>Ahmadian M, Suh JM, Hah N, et al. PPARγ signaling and metabolism: the good, the bad and the future. <em>Nat Med</em>. 2013;19(5):557–566.</li><li>Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARγ. <em>Annu Rev Biochem.</em> 2008;77:289–312.</li><li>Chi J, Wu Z, Choi CHJ, et al. Three-dimensional adipose tissue imaging reveals regional variation in beige fat biogenesis and PRDM16-dependent sympathetic neurite density. <em>Cell Metab</em>. 2018;27(1): 226–236.e3</li><li>Cohen P, Spiegelman BM. Brown and beige fat: Brown and Beige Fat: Molecular Parts of a Thermogenic Machine. <em>Diabetes</em>. 2015;64(7):2346–2351.</li><li>Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. <em>Nature</em>. 2008;453(7196):783–787.</li><li>Arner P, Spalding KL. Fat cell turnover in humans. <em>Biochem Biophys Res Commun</em>. 2010;396(1):101–104.</li><li>O’Rourke RW, White AE, Metcalf MD, et al. Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. <em>Diabetologia</em>. 2011;54(6):1480–1490.</li><li>O’Rourke RW, Metcalf MD, White AE, et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. <em>Int J Obes (Lond)</em>. 2009;33(9):978–990.</li><li>Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. <em>J Clin Invest</em>. 2003;112(12):1796–1808.</li><li>Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. <em>J Clin Invest</em>. 2003;112(12):1821–1830.</li><li>Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. <em>Cell</em>. 2008;135(2):240–249.</li><li>Birsoy K, Berry R, Wang T, et al. Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis. <em>Development.</em> 2011;138(21):4709–4719.</li><li>Schwalie PC, Dong H, Zachara M, et al. A stromal cell population that inhibits adipogenesis in mammalian fat depots. <em>Nature</em>. 2018;559(7712):103–108.</li><li>Gubelmann C, Schwalie PC, Raghav SK, et al. Identification of the transcription factor ZEB1 as a central component of the adipogenic gene regulatory network. <em>Elife</em>. 2014;3:e03346.</li><li>Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104(4):531–543.</li><li>Cohen P, Kajimura S. The cellular and functional complexity of thermogenic fat. <em>Nat Rev Mol Cell Biol</em>. 2021;22(6):393–409.</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/0*n0A4Kj3i0EU_PZr-" /></figure><p><strong>DR. CHRISTY KESTNER<br>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/450/0*pChMR4IH71NHV7qD" /></figure><p><strong>NELLY AGHEKYAN</strong></p><p><strong>Contributing Artist </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Nelli Aghekyan, did a bachelor’s and master’s in Architecture in Armenia, after studying architecture and interior design for 6 years, she concentrated on her drawing skills and continued her path in the illustration world. She works mainly on children’s book illustrations, some of her books are now being published. Currently living in Italy, she works as a full-time freelance artist, collaborating with different companies and clients.</p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*hY4rdD6bm5_jIsIO" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">https://linktr.ee/p3.illustration</a></p><h4>About the series:</h4><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fde65f414ded" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Granulosa Cells]]></title>
            <link>https://sci-illustratestories.medium.com/granulosa-cells-72cff7b28cdc?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/72cff7b28cdc</guid>
            <category><![CDATA[body]]></category>
            <category><![CDATA[fertility]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Thu, 04 Dec 2025 09:27:18 GMT</pubDate>
            <atom:updated>2025-12-04T09:27:18.354Z</atom:updated>
            <content:encoded><![CDATA[<p>Fueling Fertility, Balancing Hormones</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*60h78kBe_Rr5g5ypp6aKOQ.gif" /></figure><p><em>Credit: Art by Olga Kurkina. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Granulosa cells are significant components of ovarian follicles. They are somatic support cells that surround and sustain the developing oocyte while orchestrating every stage of follicle maturation. Far from passive bystanders, they are metabolically active conductors of hormone synthesis, follicular development, and reproductive timing. Derived from the ovarian surface epithelium, granulosa cells proliferate in sync with the oocyte, forming a multilayered follicular environment that shapes fertility from a foundational level.</p><h4><strong>Follicular Formation and Specialization</strong></h4><p>Initially, in primordial cells (the most immature stage of ovarian follicles), granulosa cells present as flattened precursors. As the follicle matures into primary and secondary stages (progressive phases in folliculogenesis marked by oocyte growth and granulosa cell proliferation), these cells transition into a cuboidal shape, denoting their increased metabolic and steroidogenic activity [1]. The transition from a monolayer to a stratified structure leads to two distinct cell populations: mural granulosa cells and cumulus granulosa cells.</p><p>Mural granulosa cells line the follicular wall and are essential for producing estradiol (a key estrogen that helps thicken the uterine lining and regulate the menstrual cycle). They express follicle-stimulating hormone (FSH) receptors and play a key role in the conversion of androgens into estrogens via the aromatase enzyme (CYP19A1) [2–3]. Meanwhile, cumulus cells form a cluster surrounding the oocyte, and are fundamental in the oocyte’s maturation and development. This occurs through paracrine signaling and metabolic transfer, while maintaining gap junctional communication. These interactions allow bidirectional signaling, with oocyte-derived growth differentiation factor 9 (GDF9) and bone morphogenic protein 15 (BMP15) [4–5].</p><h4><strong>Endocrine Coordination</strong></h4><p>Granulosa cells respond to key hormones, FSH (follicle-stimulating hormone) and LH (luteinizing hormone), to help guide the stages of follicle development. In the early phases, FSH tells granulosa cells to produce aromatase, an enzyme that helps make estrogen. They also produce anti-Müllerian hormone (AMH), which helps control how many follicles start to grow at once and protects the long-term egg supply [6–7]. By the time the follicle matures, granulosa cells have generated receptors for LH. This allows them to prepare for and wait for the LH surge that triggers ovulation. This surge sets off a cascade of genetic switches that push the follicle towards ovulation and prepare it for the next phase [8–9]. After ovulation, granulosa cells change into luteal cells, start making progesterone (a hormone essential for preparing the uterus for implantation and supporting early pregnancy), and stop producing estrogen.</p><h4><strong>The Ovulatory Switch</strong></h4><p>The LH surge plays a critical role in the transition of granulosa cells from a proliferative state to pro-ovulatory agents during the ovulatory process. This surge sets off a chain reaction of events that activate enzymes, like matrix metalloproteinases (MMPs), which break down parts of the follicle wall [10]. This remodeling process is essential because it allows the mature egg to be released from the follicle during ovulation. This transformation is closely regulated, involving exact changes in cytoskeleton configuration, extracellular matrix digestion, and vascular recruitment to promote rupture as well as luteinization.</p><h4><strong>From Harmony to Dysfunction</strong></h4><p>When granulosa cells malfunction, reproductive outcomes suffer. Conditions such as polycystic ovary syndrome (PCOS) involve granulosa cells showing disrupted follicle-stimulating hormone (FSH) signaling and elevated androgen levels, leading to follicular arrest, which is a crucial factor in women’s reproductive health and fertility [11]. In another condition, premature ovarian insufficiency (POI), depleted or apoptotic granulosa cells halt early to cease the reproductive function. Finally, granulosa cell tumors serve as a different pathological state characterized by uncontrolled proliferation of cells and excessive estrogen production, which objectifies their powerful endocrine role within ovarian physiology [12].</p><p>These cells have served as critical biomarkers of assisted reproductive technologies (ART), with their gene expression profiles and steroidogenic activities reflecting an oocyte’s potential embryo quality. For example, changes in hormone expression of hormones like estradiol were found to impact oocyte maturation and the subsequent development of embryos [13]. Their gene expression, steroid profiles, and sensitivity to gonadotropins have served as biomarkers for oocyte quality and embryo potential. This has offered critical insights into IVF outcomes.</p><h4><strong>Orchestrating More Than Ovulation</strong></h4><p>Outside of the ovary, granulosa cells play a crucial role in managing systemic hormonal balance. Their secretion of estrogen and progesterone regulates uterine preparedness, influences the hypothalamic-pituitary-ovarian axis, and impacts broader metabolic and cardiovascular health. Any dysfunction or loss of granulosa cell activity affects numerous organs, highlighting their importance as hormonal monitors, not merely as facilitators of fertility.</p><p>In conclusion, while the contributions of granulosa cells may still not be fully understood, they are essential for every successful ovulation and potential pregnancy. They orchestrate whole reproductive processes, from arranging the egg sac to maintaining hormonal homeostasis, and nurturing the oocyte as it transitions into progesterone-producing luteal cells. In fertility research and clinical settings, these cells are seen not just as tools for reproduction but also as potential therapeutic targets for hormonal imbalances, ageing issues, and infertility challenges. Subtle yet essential, granulosa cells shape the hormonal symphony behind every ovulation and pregnancy.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Pepin Lab: Massachusetts General Hospital, Boston, MA, USA <a href="https://www.pepinlab.com/">https://www.pepinlab.com/</a> , LinkedIn: <a href="https://www.linkedin.com/in/david-pepin-02762133/">https://www.linkedin.com/in/david-pepin-02762133/</a> , X: @pepinlab</li><li>Telfer Lab: University of Edinburgh, Edinburgh, Scotland <a href="https://www.research.ed.ac.uk/en/persons/evelyn-telfer">https://www.research.ed.ac.uk/en/persons/evelyn-telfer</a></li><li>Suh Lab: Columbia University, New York, NY, USA <a href="https://www.yousinsuhlab.org/">https://www.yousinsuhlab.org/</a></li><li>Conley Lab: University of California, Davis, CA, USA <a href="https://www.vetmed.ucdavis.edu/faculty/alan-conley">https://www.vetmed.ucdavis.edu/faculty/alan-conley</a>, FB: <a href="https://www.facebook.com/UCDavisVetMed">https://www.facebook.com/UCDavisVetMed</a>, IG: @ucdavisvetmed , X: @ucdavisvetmed</li><li>Walton Lab: University of Queensland, St Lucia, Australia <a href="https://biomedical-sciences.uq.edu.au/research/groups/reproductive-growth-factors">https://biomedical-sciences.uq.edu.au/research/groups/reproductive-growth-factors</a> , FB: <a href="https://www.facebook.com/uniofqld">https://www.facebook.com/uniofqld</a>, LinkedIn: <a href="https://www.linkedin.com/school/university-of-queensland/">https://www.linkedin.com/school/university-of-queensland/</a>, IG: @uniofqld, X:@uqnews</li><li>Garcia-Guerra Lab: Ohio State, Columbus, OH, USA <a href="https://u.osu.edu/osurepro/research/">https://u.osu.edu/osurepro/research/</a></li><li>Seli Lab: Yale School of Medicine, New Haven, CT, USA <a href="https://medicine.yale.edu/profile/emre-seli/">https://medicine.yale.edu/profile/emre-seli/</a> , IG: @seli.lab</li><li>So-Youn Kim Lab: University of Nebraska Medical Center, Omaha, NE, USA <a href="https://www.unmc.edu/obgyn/research/academic-research/kim/index.html">https://www.unmc.edu/obgyn/research/academic-research/kim/index.html</a>, FB: <a href="https://www.facebook.com/unmccom">https://www.facebook.com/unmccom</a>, X: @UNMCCOM</li><li>Clark Lab: UCLA, Los Angeles, CA, USA <a href="https://clark.mcdb.ucla.edu/research/">https://clark.mcdb.ucla.edu/research/</a></li><li>Pisarska Lab: Cedars-Sinai, Los Angeles, CA, USA <a href="https://www.cedars-sinai.edu/health-sciences-university/research/labs/pisarska.html">https://www.cedars-sinai.edu/health-sciences-university/research/labs/pisarska.html</a> , FB: <a href="https://www.facebook.com/CedarsSinaiHealthSciencesUniversity/">https://www.facebook.com/CedarsSinaiHealthSciencesUniversity/</a>, LinkedIn: <a href="https://www.linkedin.com/company/cedars-sinai-health-sciences-university/">https://www.linkedin.com/company/cedars-sinai-health-sciences-university/</a> , IG: @cedarssinaihsu</li></ol><h4><strong>References</strong></h4><ol><li>Wang XL, Wu Y, Tan LB, et al. Follicle-stimulating hormone regulates pro-apoptotic protein Bcl-2-interacting mediator of cell death-extra long (BimEL)-induced porcine granulosa cell apoptosis. <em>J Biol Chem</em>. 2012;287(13):10166–10177. doi:10.1074/jbc.M111.293274</li><li>Matsui T, Manabe N, Goto Y, Inoue N, Nishihara S, Miyamoto H. Expression and activity of Apaf1 and caspase-9 in granulosa cells during follicular atresia in pig ovaries. <em>Reproduction</em>. 2003;126(1):113–120. doi:10.1530/rep.0.1260113</li><li>Wang X, Li C, Wang Y, Li L, Han Z, Wang G. UFL1 Alleviates LPS-Induced Apoptosis by Regulating the NF-κB Signaling Pathway in Bovine Ovarian Granulosa Cells. <em>Biomolecules</em>. 2020;10(2):260. Published 2020 Feb 9. doi:10.3390/biom10020260</li><li>Maeda A, Goto Y, Matsuda-Minehata F, Cheng Y, Inoue N, Manabe N. Changes in expression of interleukin-6 receptors in granulosa cells during follicular atresia in pig ovaries. <em>J Reprod Dev</em>. 2007;53(4):727–736. doi:10.1262/jrd.19011</li><li>Nakayama M, Manabe N, Inoue N, Matsui T, Miyamoto H. Changes in the expression of tumor necrosis factor (TNF) alpha, TNFalpha receptor (TNFR) 2, and TNFR-associated factor 2 in granulosa cells during atresia in pig ovaries. <em>Biol Reprod</em>. 2003;68(2):530–535. doi:10.1095/biolreprod.102.004820</li><li>Aghssa MM, Tarafdari AM, Tehraninejad ES, et al. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation. <em>Reprod Health</em>. 2015;12:85. Published 2015 Sep 10. doi:10.1186/s12978–015–0053–4</li><li>Yucel Cicek OS, Gezer S, Cakir O, Hekimoglu Gurbuz R. Extremely high anti-Mullerian hormone levels detected during infertility workup revealing sex cord tumor with annular tubules and underlying Peutz-Jeghers syndrome: A case report. <em>J Obstet Gynaecol Res</em>. 2022;48(2):492–496. doi:10.1111/jog.15107</li><li>Ren YA, Liu Z, Mullany LK, Fan CM, Richards JS. Growth Arrest Specific-1 (GAS1) Is a C/EBP Target Gene That Functions in Ovulation and Corpus Luteum Formation in Mice. <em>Biol Reprod</em>. 2016;94(2):44. doi:10.1095/biolreprod.115.133058</li><li>Jin H, Won M, Park SE, Lee S, Park M, Bae J. FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Müllerian Hormone in Human Granulosa Cells. <em>PLoS One</em>. 2016;11(7):e0159112. Published 2016 Jul 14. doi:10.1371/journal.pone.0159112</li><li>Naredi N, Singh SK, Sharma R. Does Perifollicular Vascularity on the Day of Oocyte Retrieval Affect Pregnancy Outcome in an <em>In Vitro</em> Fertilization Cycle?. <em>J Hum Reprod Sci</em>. 2017;10(4):281–287. doi:10.4103/jhrs.JHRS_43_17</li><li>Mao Z, Fan L, Yu Q, et al. Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome. <em>Reprod Sci</em>. 2018;25(3):372–383. doi:10.1177/1933719117715129</li><li>Nishimura H, Ikawa Y, Kajikawa E, et al. Maternal epigenetic factors in embryonic and postnatal development. <em>Genes Cells</em>. 2023;28(6):422–432. doi:10.1111/gtc.13024</li><li>Yang G, Yao G, Xu Z, et al. Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development. <em>Front Cell Dev Biol</em>. 2021;9:647522. Published 2021 Apr 12. doi:10.3389/fcell.2021.647522</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/0*HNOSMvKA6ylomh89" /></figure><p><strong>DR. CHRISTY KESTNER<br>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*sspqg8tn6JzxlBBl" /></figure><p><strong><em>OLGA KURKINA</em></strong></p><p><strong><em>Contributing Artist The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></strong></p><p>My passion for art and love for medicine led me to the field of medical illustration, a profession in which I have been dedicated for many years. Through my work, I have the privilege of meeting and collaborating with remarkable individuals — doctors and scientists who are at the forefront of global scientific advancements. Their dedication and discoveries continue to inspire me. As a medical illustrator at a medical communications agency, my primary role is to transform complex processes and concepts into visually appealing and easily understandable images that become part of an animation or publication. Additionally, my works have been featured in numerous scientific magazines and books. Now I live and work in Poland.</p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*y3O9h9yQGV93DgQf" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">p3.illustration Official: Instagram, Twitter | Linktree</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=72cff7b28cdc" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Thecal cells]]></title>
            <link>https://sci-illustratestories.medium.com/thecal-cells-1ab83de2c448?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/1ab83de2c448</guid>
            <category><![CDATA[science]]></category>
            <category><![CDATA[fertility]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Thu, 13 Nov 2025 09:49:26 GMT</pubDate>
            <atom:updated>2025-11-13T09:49:26.779Z</atom:updated>
            <content:encoded><![CDATA[<p><em>The hidden players of the ovary</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*Od11KvO9a5DaLlw6yx5-AQ.gif" /></figure><p><em>Credit: Art by Olga Kurkina. Set in motion by Dr. Emanuele Petretto. Words by Dr. Suruchi Poddar. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><h4>The female fertility squad and their hormonal magic</h4><p>Thecal cells are found in the follicles of mammals, where they are essential for various aspects of female physiology. They originate within secondary follicles and differentiate into two main types: theca interna and theca externa. The theca interna contains vascular endothelial cells and immune cells, while the theca externa is mainly made up of fibroblast-like cells (1). One key role of the theca interna is participating in steroidogenesis, which means it helps convert cholesterol into steroid hormones such as androgens. The full function of theca externa is still not well understood. Overall, thecal cells are important because they provide structural support for the follicle and produce androgens, which are used by neighbouring granulosa cells to create estradiol, a hormone vital for reproduction. Thecal cells are well-differentiated and display structural traits typical of steroid-producing cells, such as numerous mitochondria with vesicular cristae, a smooth endoplasmic reticulum, and lipid droplets (2). Understanding the characteristics and development of thecal cells is crucial for grasping how ovarian follicles function and how female fertility is regulated throughout reproductive life.</p><h4><strong>Life span of thecal cells</strong></h4><p>The lifespan of thecal cells is closely linked to the overall dynamics of the process of folliculogenesis (maturation of the ovarian follicle). The growth and development of the follicle is a lengthy process and may require almost a year for the primordial follicle to reach the ovulatory stage (3). The two major terminal processes of the mature theca cells present in the follicles are atresia and ovulation. During atresia, follicles undergo degeneration without the release of an oocyte (4), whereas in ovulation, the follicles reach maturity and rupture to release an oocyte in the fallopian tube (5). Atresia is a fundamental process in ovarian follicles that is intrinsically connected to the cell’s natural cell death. This process happens in different cell types and can occur in various ways, including apoptosis, autophagy, necrosis, and cornification. Thecal cells appear to be especially susceptible to cell death early in follicular development, and extensive hypertrophy of these cells has been documented during atresia in humans, rats, and rabbits (2). In this terminal process, thecal cells exhibit more fibroblast-like characteristics along with diminished capability of androgen production (6). Depending on the fate of antral follicles, the terminal forms of theca cells are likely to differ. Maximum luteinization followed by apoptotic disappearance is observed in theca interna cells of ovulating follicles, whereas hypertrophied and hormonally inert fibrocytes are prominent in theca cells of atretic follicles (7).</p><h4><strong>Importance of Thecal Cells in Reproductive Health</strong></h4><p>Thecal cells are essential for proper ovarian function, directly shaping fertility and menstrual cycle regulation. Their primary role is the synthesis of androgens under stimulation from luteinizing hormone (LH), which are then converted by granulosa cells into estrogens through aromatase. This androgen–estrogen interplay is fundamental for follicle maturation, ovulation, and preparation of the endometrium for implantation (8). Beyond steroidogenesis, thecal cells also secrete growth factors and cytokines that govern follicle growth and angiogenesis while coordinating with granulosa cells to ensure synchronized follicular development. Disruption of thecal cell function can result in hormonal imbalance and reproductive disorders such as polycystic ovary syndrome (PCOS) or anovulation (9). 3D thecal cell models are beneficial in organoid development, enabling the creation of native microenvironments that mimic in vitro fertilisation efficacy, thereby facilitating personalised medicine and cell-based therapies for ovarian dysfunction (10). Despite their indirect roles, by contributing to both the structural and endocrine functions of the ovarian follicle, thecal cells are indispensable regulators of female reproductive health, and thus represent critical targets for advancing fertility research and therapeutic strategies.</p><h4>Recognizing and appreciating the labs working in this space</h4><ul><li>Astapova Lab, University of Rochester Medical Center. Rochester, New York, USA. <a href="https://www.urmc.rochester.edu/labs/astapova">https://www.urmc.rochester.edu/labs/astapova</a></li><li>Woodruff Lab, East Lansing, Michigan, USA. <a href="https://woodrufflab.org/">https://woodrufflab.org/</a></li><li>Reproductive Endocrinology Lab , Weill Cornell Medicine, New York, USA. <a href="https://reproendolab.weill.cornell.edu/team/daylon-james">https://reproendolab.weill.cornell.edu/team/daylon-james</a> X: @WeillCornell</li><li>Janette McAllister, Penn State College of Medicine, Pennsylvania, USA. <a href="https://pure.psu.edu/en/persons/janette-mcallister">https://pure.psu.edu/en/persons/janette-mcallister</a> Instagram: @pennstatecollegeofmedicine</li><li>Clark Lab, University of California, Los Angeles, USA. <a href="https://clark.mcdb.ucla.edu/">https://clark.mcdb.ucla.edu/</a> , X: @clarklabucla1</li><li>Dr. Andrea Cupp’s Lab, University of Nebraska-Lincoln, Nebraska, USA. ​​<a href="https://animalscience.unl.edu/research/research-areas/physiology-research/dr-andrea-cupps-laboratory/">https://animalscience.unl.edu/research/research-areas/physiology-research/dr-andrea-cupps-laboratory/</a> , X: @UNL_AniSci</li><li>Elisabet Stener-Victorin’s research group, Karolinska Institute, Stockholm, Sweden. <a href="https://morgridge.org/profile/james-thomson/">https://morgridge.org/profile/james-thomson/</a> , Bluesky: @ki.se</li><li>The Curry Lab, University of Kentucky College of Medicine, Kentucky, USA. <a href="https://medicine.uky.edu/departments/obgyn/curry-lab">https://medicine.uky.edu/departments/obgyn/curry-lab</a> , X: @UKYMedicine</li><li>Francisco Diaz Lab, Department of Animal Science, Penn State College of Agricultural Studies, Pennsylvania, USA. <a href="https://animalscience.psu.edu/research/labs/diaz">https://animalscience.psu.edu/research/labs/diaz</a></li></ul><h4><strong>References</strong></h4><ol><li>Liu, T., Qin, Q. Y., Qu, J. X., Wang, H. Y., &amp; Yan, J. (2020). Where are the theca cells from: the mechanism of theca cells derivation and differentiation. Chinese medical journal, 133(14), 1711–1718. <a href="https://doi.org/10.1097/CM9.0000000000000850">https://doi.org/10.1097/CM9.0000000000000850</a></li><li>Young, J. M., &amp; McNeilly, A. S. (2010). Theca: the forgotten cell of the ovarian follicle. <em>Reproduction (Cambridge, England)</em>, <em>140</em>(4), 489–504. <a href="https://doi.org/10.1530/REP-10-0094">https://doi.org/10.1530/REP-10-0094</a></li><li>Williams CJ, Erickson GF. Morphology and Physiology of the Ovary. [Updated 2012 Jan 30]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK278951/">https://www.ncbi.nlm.nih.gov/books/NBK278951/</a></li><li>Zhou, J., Peng, X., &amp; Mei, S. (2019). Autophagy in Ovarian Follicular Development and Atresia. International journal of biological sciences, 15(4), 726–737.<a href="https://doi.org/10.7150/ijbs.30369"> https://doi.org/10.7150/ijbs.30369</a></li><li>Holesh JE, Bass AN, Lord M. Physiology, Ovulation. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:<a href="https://www.ncbi.nlm.nih.gov/books/NBK441996/"> https://www.ncbi.nlm.nih.gov/books/NBK441996/</a></li><li>Hsueh, A. J., Billig, H., &amp; Tsafriri, A. (1994). Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocrine reviews, 15(6), 707–724.<a href="https://doi.org/10.1210/edrv-15-6-707"> https://doi.org/10.1210/edrv-15-6-707</a></li><li>Tajima, K., Orisaka, M., Mori, T., &amp; Kotsuji, F. (2007). Ovarian theca cells in follicular function. <em>Reproductive biomedicine online</em>, <em>15</em>(5), 591–609.<a href="https://doi.org/10.1016/s1472-6483(10)60392-6"> https://doi.org/10.1016/s1472-6483(10)60392-6</a></li><li>Reed BG, Carr BR. The Normal Menstrual Cycle and the Control of Ovulation. [Updated 2018 Aug 5]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from:<a href="https://www.ncbi.nlm.nih.gov/sites/books/NBK279054/"> https://www.ncbi.nlm.nih.gov/sites/books/NBK279054/</a></li><li>Jozkowiak, M., Piotrowska-Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P., Kempisty, B., Rachon, D., &amp; Spaczynski, R. Z. (2022). Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction. Cells, 12(1), 174.<a href="https://doi.org/10.3390/cells12010174"> https://doi.org/10.3390/cells12010174</a></li><li>Del Valle, J. S., &amp; Chuva de Sousa Lopes, S. M. (2023). Bioengineered 3D Ovarian Models as Paramount Technology for Female Health Management and Reproduction. Bioengineering (Basel, Switzerland), 10(7), 832. <a href="https://doi.org/10.3390/bioengineering10070832">https://doi.org/10.3390/bioengineering10070832</a></li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/proxy/0*cr6_ikunl_qi4ZwG" /></figure><p><strong>DR. SURUCHI PODDAR</strong></p><p><strong>Content Editor </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Poddar received a PhD in Biomedical Engineering from Indian Institute of Technology-Banaras Hindu University (IIT-BHU), Varanasi, India. She started her career as a postdoctoral researcher in 2020 with the Nanoscience Technology Center at the University of Central Florida, Orlando where she worked on a multi-organ human-on-a-chip system. Currently she is working on solid-state nanopore technology at Wake Forest University, North Carolina. When not working, she enjoys watching movies, cooking food and exploring new places, restaurants, attractions.</p><h4>About the artists:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/0*SDdud_q-8q8cNjhR" /></figure><p><strong><em>OLGA KURKINA</em></strong></p><p><strong><em>Contributing Artist The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></strong></p><p>My passion for art and love for medicine led me to the field of medical illustration, a profession in which I have been dedicated for many years. Through my work, I have the privilege of meeting and collaborating with remarkable individuals — doctors and scientists who are at the forefront of global scientific advancements. Their dedication and discoveries continue to inspire me. As a medical illustrator at a medical communications agency, my primary role is to transform complex processes and concepts into visually appealing and easily understandable images that become part of an animation or publication. Additionally, my works have been featured in numerous scientific magazines and books. Now I live and work in Poland.</p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/proxy/0*mxEPBt5JZ1MvTw47" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">https://linktr.ee/p3.illustration</a></p><h4>About the series:</h4><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1ab83de2c448" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Sertoli Cells]]></title>
            <link>https://sci-illustratestories.medium.com/sertoli-cells-9e6ea4d6cf69?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/9e6ea4d6cf69</guid>
            <category><![CDATA[body]]></category>
            <category><![CDATA[fertility]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Wed, 15 Oct 2025 21:50:25 GMT</pubDate>
            <atom:updated>2025-10-15T21:50:25.594Z</atom:updated>
            <content:encoded><![CDATA[<p>Masters of Male Reproductive Order</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*oBPu2W0tphcRh8hoWpXvig.gif" /></figure><p><em>Credit: Art by Renske Hoste. Set in motion by Dr. Emanuele Petretto. Words by Dr. Christy Kestner. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em><a href="https://medium.com/u/ccac64a301b2"><em> Radhika Patnala</em></a></p><p><a href="https://www.sci-illustrate.com/"><em>Sci-Illustrate</em></a><em>, </em><a href="https://www.endosymbiont.com/"><em>Endosymbiont</em></a></p><p><em>#Extraordinarycelltypes #sciart #lifescience</em></p><p>Sertoli cells are the maestros of testicular architecture and sentinels of germ cell development. First described by Enrico Sertoli in 1865, these elongated somatic cells reside within the seminiferous tubules of the testes. Although initially underappreciated, decades of research have revealed their central role in male reproductive biology. Far from oblivious bystanders, sertoli cells provide structural support, construct an immune barrier, and secrete signaling molecules that guide spermatozoa development. Fundamental research into sertoli cell organization [1], the identification and definition of the secondary sex tissues’ role in sex determination [2], and the lineage-tracing work [3] have aided in defining Sertoli cells not just as “nurse cells,” but as the conductors of spermatogenic symphony.</p><p><strong>The Architects of the Testis</strong></p><p>Lining the seminiferous tubule walls, these specialized somatic cells construct the microenvironment where sperm are born. Both sentinels and scaffolding also help organize germ cells in an extremely ordered, layered manner, one analogous to temporal and spatial choreography of spermatogenesis. The blood-testis barrier (BTB), a tight junctional complex between adjacent Sertoli cells, compartmentalizes the seminiferous epithelium into adluminal and basal regions. This organization protects developing germ cells from immune surveillence and restricts molecular permeation to ensure Sertoli cells regulate what enters the germ cell microenvironment [4–6].</p><p><strong>The Sustainers of Spermatogenesis</strong></p><p>Spermatogenesis is metabolically costly, tightly controlled, and depends upon Sertoli cells for more than protection. They carry lactate, transferrin, and other nutrients to germ cells. They phagocytose the residual cytoplasm of forming spermatids and respond to hormonal cues like FSH and testosterone to synchronize their actions with the requirements of germ cells [1, 7]. Experiments using genetic and hormonal manipulation in rodent models have helped define how FSH regulates Sertoli cell transcriptional networks to initiate and sustain spermatogenesis [1]. These studies show that FSH promotes Sertoli cell proliferation and modulates gene expression critical for germ cell support. Related research has also provided insight into Sertoli cell behavior in testicular organoid systems, where dissociated neonatal testis cells self-organize into seminiferous tubule–like structures capable of supporting germ cell development up to the meiotic phase [8].</p><p><strong>Censors of Immunological Intruders</strong></p><p>Among their most fascinating roles, Sertoli cells help maintain the testes as an immune-privileged site — a biological environment where immune responses are actively suppressed to protect developing germ cells. Because these germ cells arise postnatally, they may be recognized as “non-self” by the immune system, making them vulnerable to autoimmune attack. To prevent this, Sertoli cells establish the blood-testis barrier (BTB) and secrete immunosuppressive factors that shield germ cells from immune surveillance [6, 9].</p><p>This unique immunological environment has made Sertoli cells a promising tool in transplantation research, where their protective properties are being explored for promoting graft tolerance beyond the reproductive system [9]. However, exposure to environmental toxins can disrupt this immunoprotection, posing long-term risks to male fertility [10].</p><p><strong>Hormonal Command Center</strong></p><p>Deeply embedded in the endocrine regulation of the male reproductive axis, these somatic cells don’t act alone. They both possess androgen receptors and FSH receptors, enabling them to respond dynamically to hormone cues. Upon FSH binding, Sertoli cells modify gene expression to facilitate germ cell survival, and testosterone fine-tunes it with paracrine signaling [1, 11]. This has been advanced by researchers showing how sensitivity of Sertoli cells to these hormones is modified by epigenetic modifiers — another level of regulatory complexity added [12].</p><p><strong>Unraveling the Unknowns</strong></p><p>From organoid systems to fertility preservation, the limelight is on Sertoli cells regarding reproductive biology. Studies continue to be centered on investigating early genetic switches, such as SOX9, that fix the fate of progenitor cells towards the Sertoli fate [2]. Meanwhile, scientists lead global efforts to reconstitute the spermatogenic niche in vitro, opening doors to novel therapies for cancer patients and azoospermic individuals [8]. Even early studies have revealed that Sertoli cell function and broader testicular physiology are influenced by circadian clock genes. In BMAL1 knockout mice, disrupted rhythmic expression of steroidogenic genes like <em>StAR</em> led to impaired testosterone production and infertility, underscoring the role of circadian regulation in male reproductive function [13].</p><p><strong>The Unsung Heroes of the Testis</strong></p><p>Though they cannot be seen with a naked eye, Sertoli cells are accountable for the visible outcome of male fertility. From orchestrating germ cell development to offering protection to the testis against invasion by the immune system, they are miracle-working multitaskers [14]. As labs worldwide continue to unravel their secrets, Sertoli cells are emerging into the scientific spotlight — not merely as supporting cells, but as the magnificoes of reproductive order.</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Griswold Lab: Washington State University, WA, USA. <a href="https://labs.wsu.edu/griswold-lab/">https://labs.wsu.edu/griswold-lab/</a></li><li>Wolgemuth Lab: Columbia University Medical Center, NY, USA. <a href="https://www.ihn.cuimc.columbia.edu/profile/debra-j-wolgemuth-phd">https://www.ihn.cuimc.columbia.edu/profile/debra-j-wolgemuth-phd</a></li><li>Behringer Lab: MD Anderson Cancer Center, TX, USA. <a href="https://www.mdanderson.org/research/departments-labs-institutes/labs/behringer-laboratory.html">https://www.mdanderson.org/research/departments-labs-institutes/labs/behringer-laboratory.html</a> , X: <a href="https://twitter.com/rrbehringer?lang=en">@rrbehringer</a></li><li>Yao Lab: NIH, National Institute of Environmental Health Sciences, USA. <a href="https://www.niehs.nih.gov/research/atniehs/labs/rdbl/pi/developmental">https://www.niehs.nih.gov/research/atniehs/labs/rdbl/pi/developmental</a></li><li>Dufour Lab: Texas Tech University Health Sciences Center, TX, USA. <a href="https://www.ttuhsc.edu/medicine/cell-biology-biochemistry/faculty/dufour.aspx">https://www.ttuhsc.edu/medicine/cell-biology-biochemistry/faculty/dufour.aspx</a> , FB: <a href="https://www.facebook.com/ttuhsc/">https://www.facebook.com/ttuhsc/</a> , IG: @ttuhsc , LinkedIn: <a href="https://www.linkedin.com/school/texas-tech-university-health-sciences-center/">https://www.linkedin.com/school/texas-tech-university-health-sciences-center/</a> , X: @TTUHSC</li><li>Toppari Lab: University of Turku, Finland. <a href="https://www.utu.fi/en/people/jorma-toppari">https://www.utu.fi/en/people/jorma-toppari</a></li><li>Koopman Lab: University of Queensland, Australia. <a href="https://imb.uq.edu.au/profile/464/peter-koopman">https://imb.uq.edu.au/profile/464/peter-koopman</a> , FB:<a href="https://www.facebook.com/uniofqldinternational/?brand_redir=137474816330115#">https://www.facebook.com/uniofqldinternational/?brand_redir=137474816330115#</a> , LinkedIn: <a href="https://www.linkedin.com/school/university-of-queensland/">https://www.linkedin.com/school/university-of-queensland/</a> , X: @uq_news</li><li>Kimmins Lab: McGill University, Montreal, Canada. <a href="https://www.chumontreal.qc.ca/en/crchum/chercheurs/sarah-kimmins">https://www.chumontreal.qc.ca/en/crchum/chercheurs/sarah-kimmins</a> , X: @KimminsSarah , Linkedin: <a href="https://www.linkedin.com/in/sarah-kimmins-33004970/">https://www.linkedin.com/in/sarah-kimmins-33004970/</a></li><li>Sassone-Corsi Center (Legacy Work): University of California, Irvine, USA. <a href="https://cempschome.wordpress.com/meet-the-lab/">https://cempschome.wordpress.com/meet-the-lab/</a> , X: @sassonecorsilab</li><li>Schlatt Lab: Centre of Reproductive Medicine and Andrology (CeRA), University of Münster, Germany. <a href="https://www.medizin.uni-muenster.de/en/cera/research/spermatogenesis-and-testis-function-schlatt/research-focus.html">https://www.medizin.uni-muenster.de/en/cera/research/spermatogenesis-and-testis-function-schlatt/research-focus.html</a></li></ol><h4><strong>References</strong></h4><ol><li>Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol. 1998;9(4):411–416.</li><li>Koopman P, Munsterberg A, Capel B, Vivian N, Lovell-Badge R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature. 1990;348(6300):450–452.</li><li>Yao HH, Capel B. Disruption of testis cords by cyclopamine or forskolin reveals independent cellular pathways in testis organogenesis. Dev Biol. 2002;246(2):356–365.</li><li>Cheng CY, Mruk DD. The blood-testis barrier and its implications for male contraception. Pharmacol Rev. 2012;64(1):16–64.</li><li>Mruk DD, Cheng CY. The mammalian blood-testis barrier: its biology and regulation. Endocr Rev. 2015;36(5):564–591.</li><li>Dufour JM, Rajotte RV, Seeberger K, Kin T, Korbutt GS. Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xenotransplantation. 2003;10(6):577–586.</li><li>Oatley JM, Brinster RL. Regulation of spermatogonial stem cell self-renewal in mammals. Annu Rev Cell Dev Biol. 2008;24:263–286.</li><li>Yokonishi T, Sato T, Katagiri K, Komeya M, Kubota Y, Ogawa T. In Vitro Reconstruction of Mouse Seminiferous Tubules Supporting Germ Cell Differentiation. Biol Reprod. 2013;89(1):15.</li><li>Dufour JM, Dass B, Halley KR, Korbutt GS, Dixon DE, Rajotte RV. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplant. 2008;17(5):525–534.</li><li>Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol. 2010;88(10):910–919.</li><li>Walker WH, Cheng J. FSH and testosterone signaling in Sertoli cells. Reproduction. 2005;130(1):15–28.</li><li>Shea JM, Serra RW, Carone BR, et al. Genetic and Epigenetic Variation, but Not Diet, Shape the Sperm Methylome. Dev Cell. 2015;35(6):750–758.</li><li>Alvarez JD, Hansen A, Ord T, et al. The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice. J Biol Rhythms. 2008;23(1):26–36.</li><li>Gu W, Gaeta X, Sahakyan A, et al. Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State. Cell Stem Cell. 2016;19(4):476–490.</li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/430/0*o4m2nvNLjDE0UhxX" /></figure><p><strong>DR. CHRISTY KESTNER</strong></p><p><strong>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Christy Kestner holds a PhD in Neuroimmunology from the Medical University of South</p><p>Carolina (MUSC), where she studied how complement drives pathological conditions related to neuroinflammation and brain injury (stroke and traumatic brain injury), as well as approaches to reduce harmful complement activation. She later conducted postdoctoral research in oncology therapeutic development, investigating new drug targets for pancreatic cancer. Dr. Kestner currently works as a scientific and medical writer, creating educational content and op-eds for science and health communication platforms. She also runs her own science communication platform, <em>Brain &amp; Beyond</em>, aimed at translating complex research into accessible content. Passionate about science storytelling, she is dedicated to making immunology and neuroscience both accurate and engaging for diverse audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*97h-7vvEyZtG76uU" /></figure><p><em>RENSKE HOSTE</em></p><p><strong><em>Contributing Artist</em></strong><em> The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p><em>Renske is a professional medical artist who spends most of her time working on anatomy and pathology in 2D and 3D. She joined as a creator of the League of Extraordinary Cell Types to challenge herself to combine science with her love for art and all things nature and growing. When not working full-time or as a freelancer, Renske loves growing things in her garden, kicking butt doing Krav Maga, or being knee-deep in various creative projects.</em></p><p><em>Social media:</em></p><p><a href="http://www.linkedin.com/in/rmhmedicalartist"><em>www.linkedin.com/in/rmhmedicalartist</em></a></p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*z-FX9WmxzlyECv1i" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">https://linktr.ee/p3.illustration</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9e6ea4d6cf69" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Ovum — Egg cell]]></title>
            <link>https://sci-illustratestories.medium.com/ovum-egg-cell-de2ba8b20242?source=rss-1c47669525b4------2</link>
            <guid isPermaLink="false">https://medium.com/p/de2ba8b20242</guid>
            <category><![CDATA[fertility]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[body]]></category>
            <category><![CDATA[science]]></category>
            <dc:creator><![CDATA[Sci-Illustrate]]></dc:creator>
            <pubDate>Thu, 04 Sep 2025 08:19:56 GMT</pubDate>
            <atom:updated>2025-09-04T08:19:56.662Z</atom:updated>
            <content:encoded><![CDATA[<h3>Ovum — Egg cell</h3><h4>A Fortress of Life</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/650/1*lpJ9TqeOW7JSsVWXQBQqyg.gif" /></figure><p><strong><em>Credit: Art by Olga Kurkina. Set in motion by Dr. Emanuele Petretto. Words by Dr. Akanksha Gandhi. Project Coordinator: Dr. Masia Maksymowicz-Trivedi. Series Director: Dr.</em></strong><a href="https://medium.com/u/ccac64a301b2"><strong><em> Radhika Patnala</em></strong></a></p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><p><strong><em>#Extraordinarycelltypes #sciart #lifescience</em></strong></p><p>Every living being on the planet today began as a single, tiny cell called an egg, a silent powerhouse that contains the code for life. For human development to begin, a sperm cell must fertilize this egg, fusing the genetic material of both parents. The complex process of human development, which starts with this single cell and covers everything from the formation of our brain to the first heartbeat, begins here. So, what is this cell, and how does it work in our body?</p><p>The female reproductive cell is called the egg cell or ovum. The egg cell is released from the ovaries in the female reproductive system. It is produced through the process of oogenesis and has the potential to develop into a new organism if fertilized by a sperm cell [1]. Egg cells are haploid, which means they have half the number of chromosomes of somatic cells (non-reproductive cells). Among countless cells that exist, it is one of the few that has the ability to create entirely new life [2].</p><h3>Structure of an Egg Cell</h3><p>With a diameter of 100 μm, the ovum is one of the largest cells in the human body, which can be seen with the unaided eye without the use of a microscope or other magnifying tool [3]. The egg is not just a cell; it’s a work of art, a little world clothed in layers of purpose and protection. The nucleus is at the centre of the cell. It is a quiet vault that holds half of the genetic code needed to make a human being. This nucleus is like a scroll of old instructions handed down through generations, waiting for its partner, the sperm, to finish the story. The cytoplasm, also known as cell plasma or yolk, surrounds the nucleus and contains nutrients, stores energy, and molecular machinery [4,5]. This is the egg’s life-support system, which provides everything an embryo requires in its first few days before connecting to a mother’s body. You may see it as packed luggage for a long trip, filled with supplies for the road ahead.</p><p>The egg cell is surrounded by three basic exterior layers. The outermost layer, the <strong>corona radiata</strong>, is composed of follicular cells that provide nourishment and protection. Beneath it lies the <strong>zona pellucida</strong>, a thick, translucent glycoprotein layer that maintains the egg’s structure and plays a crucial role in fertilization by enabling sperm binding and preventing polyspermy (fertilization by more than one sperm) [6,7]. The innermost layer, the <strong>vitelline membrane</strong>, is a delicate wall encasing the egg’s contents, offering an additional barrier against potential damage.</p><h3><strong>The Life Story of an Ovum — Oogenesis</strong></h3><p><strong>Multiplication phase</strong></p><p>The ovaries of a baby girl start working long before she is born. <strong>Oogonia</strong>, which are tiny cells, begin to form around the 6th to 7th week of pregnancy. They proliferate quickly by a process known as mitosis — a type of cell division that produces exact duplicates of a cell, somewhat like in a biological copying machine. This serves to multiply their numbers in a short time. However, although thousands are produced, the majority of them will gradually degenerate, and only a few fortunate ones will progress to the next level towards becoming a mature egg [8].</p><p><strong>Growth phase</strong></p><p>The oogonia that do not degenerate differentiate into a <strong>primary oocyte.</strong> The growth is linked with both nuclear and cytoplasmic growth. The nuclear growth is caused by the accumulation of large quantities of nuclear sap and is referred to as a germinal vesicle. The cytoplasmic growth is linked to an increase in the number of mitochondria, endoplasmic reticulum, the Golgi complex and accumulation of reserve food material. Each primary oocyte is shielded by a tiny bubble of support cells known as a follicle [9].</p><p><strong>Maturation phase</strong></p><p>During puberty, hormones instruct a few follicles to wake up every month. Most of them don’t make it, but one egg usually gets old enough to keep going. The selected primary oocyte completes the first half of meiosis and turns into a secondary oocyte, with a smaller byproduct, a polar body (which does not develop into an egg). The secondary oocyte begins the second half of meiosis, but once again halts, this time at a stage known as metaphase II, and awaits fertilization [10].</p><p><strong>Fertilization</strong></p><p>The egg completes meiosis rapidly if a sperm makes it to the secondary oocyte and fertilizes it successfully. The outcome? Creation of the first human cell, called a zygote. A zygote is the first stage of life and has 46 chromosomes, 23 from each parent. In the absence of fertilization, the secondary oocyte simply decomposes, and the body initiates a new menstrual cycle [11].</p><h3><strong>The Ovum’s Big Responsibilities</strong></h3><p>Each egg cell has 23 chromosomes — that’s half of the genetic information necessary to create a human being. The other half is contributed by the sperm. Together, they decide traits such as eye color, hair type, and even the risk for certain inherited diseases [12].</p><p>When a healthy sperm encounters a mature egg, fertilization can take place. The sperm and egg unite their DNA to create a brand new cell known as a zygote. The outer shell of the egg is smart too — it hinders any additional sperm after one enters, to ensure only one fertilization occurs. This protection system is precisely timed. <strong>Fetuin-B</strong> is a protein that regulates the hardening of the egg’s shell, keeping it flexible enough to enable sperm access at the correct time but then switching to block all others after fertilization occurs. In mouse experiments, the absence of Fetuin-B causes the shell to harden too early, limiting fertilization entirely, whereas too much can delay hardening and risk access by sperms [13]. This delicate harmony demonstrates how well the egg maintains the open and closed signs on its surface.</p><p>The egg’s cytoplasm, or jelly-like interior, contains nutrients that nourish the early-stage embryo (known as a blastocyst) at the very beginning, before the embryo even reaches the uterus. These nutrients enable it to grow and live until it implants in the uterus and becomes attached to the mother’s bloodstream, eventually turning into the placenta. Apart from their role in nutrition, the cytoplasm also contains molecular gear that guarantees the process of egg division is proper. To split chromosomes equally, a microscopic structure known as the spindle must be precisely positioned. Because egg cells don’t have the structures that other cells possess, they create mild currents in their cytoplasm that hold the spindle in place. These currents are driven by motor proteins and actin filaments [14].</p><p>Once a sperm passes through the egg’s protective coat, it reaches the egg’s outer skin, known as the oolemma. A very distinctive handshake occurs here:<strong> IZUMO1</strong>, a protein on the sperm, binds effectively with <strong>JUNO</strong>, its matching companion on the egg [15]. Without these two molecules, the two cells cannot join, and fertilization ceases before it begins. Scientists discovered that if either IZUMO1 or JUNO is missing, no embryo can form, demonstrating how important this moment of recognition is in beginning a new life [16].</p><h4><strong>Growing Eggs Outside the Body: A Glimpse into the Future</strong></h4><p>Recently, scientists have accomplished something that previously seemed impossible: they have successfully grown human egg cells from the earliest stage to full maturity outside of the body [17,18]. Eggs take many years to develop and mature inside a woman’s ovary. But in this new technique, scientists were able to duplicate that complicated process entirely in the lab. What makes this breakthrough so remarkable? These cells have resisted artificial cultivation for more than 30 years because they are extremely sensitive to their external environment. But now? The spell has been broken. The lab turns into a warm milieu of potential, a surrogate ovary. This is a reproductive biology revolution rather than merely a lab success [19]. This milestone is a ray of hope that becoming a mother won’t be prevented by age, diseases, or other circumstances. It may eventually aid in the development of new infertility treatments and regenerative medicine therapies [20,21].</p><h4><strong>Recognizing and appreciating the labs working in this space</strong></h4><ol><li>Dr. Carlos Telleria’s lab, Experimental Pathology Unit, Department of Pathology, McGill University, Montreal, QC H3A 2B4, Canada. <a href="https://www.mcgill.ca/pathology/carlos-telleria"><strong>https://www.mcgill.ca/pathology/carlos-telleria</strong></a></li><li>Schindler lab, Department of Genetics at Rutgers University, New Jersey. <a href="https://sites.rutgers.edu/schindler-lab/research/">https://sites.rutgers.edu/schindler-lab/research/</a></li><li>Dr. Elvan Böke’s lab, Centre for Genomic Regulation, Barcelona, Spain. <a href="https://www.crg.eu/en/elvan-boke#block-block-2">https://www.crg.eu/en/elvan-boke#block-block-2</a>, X: @LabBoke</li><li>Prof. A. Gutierrez-Adan, Departamento de Reproducción Animal, INIA-CSIC, Avenida Puerta de Hierro 12. Local 10, 28040 Madrid, Spain. <a href="https://laborepro.wixsite.com/gutierrez-adan">https://laborepro.wixsite.com/gutierrez-adan</a></li><li>Elnur Babayev, Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. <a href="https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=55663">https://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=55663</a></li><li>Eyelyn Telfer, Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, UK. <a href="https://edwebprofiles.ed.ac.uk/profile/evelyn-telfer">https://edwebprofiles.ed.ac.uk/profile/evelyn-telfe</a>, X: @EdinUni_CRH</li><li>Christopher Thomas,<strong> </strong>The Marseille Developmental Biology Institute (IBDM), Marseille, France. <a href="https://www.ibdm.univ-amu.fr/team/control-and-dynamics-of-the-ovarian-cycle/">https://www.ibdm.univ-amu.fr/team/control-and-dynamics-of-the-ovarian-cycle/</a> X: @LastChrisThomas</li><li>Schuh lab, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. <a href="https://www.mpinat.mpg.de/639000/Research">https://www.mpinat.mpg.de/639000/Research</a>, X: <a href="https://x.com/SchuhLab">@SchuhLab</a></li><li>Dr Ali Abbara, Department of Metabolism, Digestion and Reproduction — Faculty of Medicine. <a href="https://profiles.imperial.ac.uk/ali.abbara/publications">https://profiles.imperial.ac.uk/ali.abbara/publications</a></li><li>Dr. Mark Nachtigal, Max Rady College of Medicine, Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada. <a href="https://research.cancercare.mb.ca/research-profile/mark-w-nachtigal/">https://research.cancercare.mb.ca/research-profile/mark-w-nachtigal/</a></li></ol><h4><strong>References</strong></h4><ol><li>Sánchez, F., &amp; Smitz, J. (2012). Molecular control of oogenesis. <em>Biochimica et Biophysica Acta (BBA) — Molecular Basis of Disease, 1822</em>(12), 1896–1912. <a href="https://doi.org/10.1016/j.bbadis.2012.05.013">https://doi.org/10.1016/j.bbadis.2012.05.013</a></li><li>Britannica. Ovum: structure, function, and fertilization. URL:<a href="https://www.britannica.com/science/ovum"> https://www.britannica.com/science/ovum</a>.</li><li>Milo R, Phillips R, Orme N. 2016. <em>Cell Biology by the Numbers</em> New York: Garland Sci.</li><li>Hadek, Robert. “The structure of the mammalian egg.” <em>International review of cytology</em> 18 (1965): 29–71.</li><li>Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Eggs. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK26842/">https://www.ncbi.nlm.nih.gov/books/NBK26842/</a></li><li>Familiari G, Relucenti M, Heyn R, Micara G, Correr S. Three-dimensional structure of the zona pellucida at ovulation. Microsc Res Tech. 2006 Jun;69(6):415–26. doi: 10.1002/jemt.20301. PMID: 16703610.</li><li>Sathananthan, A. H. (1997). Ultrastructure of the human egg. <em>Human Cell, 10</em>(1), 21–38. PMID: 9234062</li><li>Krajnik, K.; Mietkiewska, K.; Skowronska, A.; Kordowitzki, P.; Skowronski, M.T. Oogenesis in Women: From Molecular Regulatory Pathways and Maternal Age to Stem Cells. <em>Int. J. Mol. Sci.</em> <strong>2023</strong>, <em>24</em>, 6837. <a href="https://doi.org/10.3390/ijms24076837">https://doi.org/10.3390/ijms24076837</a></li><li>Holesh, J. E., Bass, A. N., &amp; Lord, M. (2023). Physiology, ovulation. In <em>StatPearls</em>. StatPearls Publishing. PMID: 28723025</li><li>Jamnongjit, M., &amp; Hammes, S. R. (2005). Oocyte maturation: The coming of age of a germ cell. <em>Seminars in Reproductive Medicine, 23</em>(3), 234–241. <a href="https://doi.org/10.1055/s-2005-872451">https://doi.org/10.1055/s-2005-872451</a></li><li>Oliver R, Basit H. Embryology, Fertilization. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: <a href="https://www.ncbi.nlm.nih.gov/books/NBK542186/">https://www.ncbi.nlm.nih.gov/books/NBK542186/</a></li><li>Jackson, M., Marks, L., May, G. H. W., &amp; Wilson, J. B. (2018). The genetic basis of disease. <em>Essays in Biochemistry, 62</em>(5), 643–723. <a href="https://doi.org/10.1042/EBC20170053">https://doi.org/10.1042/EBC20170053</a></li><li>Dietzel, E., J. Floehr, and W. Jahnen-Dechent. “The biological role of fetuin-B in female reproduction.” <em>Ann Reprod Med Treat</em>1.1 (2016): 1003.</li><li>Yi, K., Rubinstein, B., &amp; Li, R. (2013). Symmetry breaking and polarity establishment during mouse oocyte maturation. <em>Philosophical Transactions of the Royal Society B: Biological Sciences, 368</em>(1629), 20130002. <a href="https://doi.org/10.1098/rstb.2013.0002">https://doi.org/10.1098/rstb.2013.0002</a></li><li>Bianchi, E.; Doe, B.; Goulding, D.; Wright, G.J. Juno is the egg Izumo receptor and is essential for mammalian fertilization. <em>Nature</em> <strong>2014</strong>, <em>508</em>, 483–487.</li><li>Aydin, Halil, et al. “Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex.” <em>Nature</em>534.7608 (2016): 562–565.</li><li>Telfer, E. E., &amp; Andersen, C. Y. (2021). In vitro growth and maturation of primordial follicles and immature oocytes. <em>Fertility and Sterility, 115</em>(5), 1116–1125. <a href="https://doi.org/10.1016/j.fertnstert.2021.03.004">https://doi.org/10.1016/j.fertnstert.2021.03.004</a></li><li>Vitale, F., &amp; Dolmans, M. M. (2024). Comprehensive review of in vitro human follicle development for fertility restoration: Recent achievements, current challenges, and future optimization strategies. <em>Journal of Clinical Medicine, 13</em>(6), 1791. <a href="https://doi.org/10.3390/jcm13061791">https://doi.org/10.3390/jcm13061791</a></li><li>Reuters. (2018). Scientists grow human eggs to full maturity in a lab <em>Reuters</em>.<a href="https://www.reuters.com/article/us-health-human-eggs/scientists-grow-human-eggs-to-full-maturity-in-a-lab-idUSKBN1FT00P/">https://www.reuters.com/article/us-health-human-eggs/scientists-grow-human-eggs-to-full-maturity-in-a-lab-idUSKBN1FT00P/</a></li><li>Matzuk, M., Lamb, D. The biology of infertility: research advances and clinical challenges. <em>Nat Med</em> 14, 1197–1213 (2008). <a href="https://doi.org/10.1038/nm.f.1895">https://doi.org/10.1038/nm.f.1895</a></li><li>Sittadjody, S., Criswell, T., Jackson, J.D. <em>et al.</em> Regenerative Medicine Approaches in Bioengineering Female Reproductive Tissues. <em>Reprod. Sci.</em> 28, 1573–1595 (2021). <a href="https://doi.org/10.1007/s43032-021-00548-9">https://doi.org/10.1007/s43032-021-00548-9</a></li></ol><h4>About the author:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*FKQOlbgYowIyeOVrZie1-A.jpeg" /></figure><p><strong>Dr. Akanksha Gandhi</strong></p><p><strong>Content Editor</strong> <em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Akanksha Gandhi earned her PhD in Molecular Biology from the Max Planck Institute for Chemical Ecology in Jena, Germany, in 2024. Prior to that, she completed her Master’s degree in Biology at the University of Texas Rio Grande Valley, USA. Her academic journey has been shaped by a deep curiosity about the natural world and a passion for scientific discovery. Outside the lab, Akanksha enjoys cooking, watching movies, and spending time outdoors, especially going for walks and hiking. She also has a growing interest in science communication and is currently exploring ways to make complex scientific ideas more accessible and engaging to broader audiences.</p><h4>About the artist:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*91AL8AtmQ-vZmWgSohe3ww.png" /></figure><p><strong><em>OLGA KURKINA</em></strong></p><p><strong><em>Contributing Artist The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></strong></p><p>My passion for art and love for medicine led me to the field of medical illustration, a profession in which I have been dedicated for many years. Through my work, I have the privilege of meeting and collaborating with remarkable individuals — doctors and scientists who are at the forefront of global scientific advancements. Their dedication and discoveries continue to inspire me. As a medical illustrator at a medical communications agency, my primary role is to transform complex processes and concepts into visually appealing and easily understandable images that become part of an animation or publication. Additionally, my works have been featured in numerous scientific magazines and books. Now I live and work in Poland.</p><h4>About the animator:</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*-7fID4w_1peX1gWi" /></figure><p><strong>DR. EMANUELE PETRETTO</strong></p><p><strong>Animator </strong><em>The League of Extraordinary Cell Types, Sci-Illustrate Stories</em></p><p>Dr. Petretto received his Ph.D. in Biochemistry at the University of Fribourg, Switzerland, focusing on the behavior of matter at nanoscopic scales and the stability of colloidal systems. Using molecular dynamics simulations, he explored the delicate interaction among particles, interfaces, and solvents.</p><p>Currently, he is fully pursuing another delicate interaction: the intricate interplay between art and science. Through data visualization, motion design, and games, he wants to show the wonders of the complexity surrounding us.</p><p><a href="https://linktr.ee/p3.illustration">https://linktr.ee/p3.illustration</a></p><h3>About the series:</h3><p><strong>The League of Extraordinary Cell types</strong></p><p>The team at Sci-Illustrate and Endosymbiont bring to you an exciting series where we dive deep into the wondrous cell types in our body, that make our hearts tick ❤.</p><p><a href="https://www.sci-illustrate.com/"><strong><em>Sci-Illustrate</em></strong></a><strong><em>, </em></strong><a href="https://www.endosymbiont.com/"><strong><em>Endosymbiont</em></strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=de2ba8b20242" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>